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Due to earlier recognition and advances in cancer treatment, increasing numbers of 
women are surviving breast cancer. In Canada, these women are transitioned back to their 
Primary Care Providers (PCPs), including Nurse Practitioners (NPs) and physicians, soon after 
their cancer treatment is complete. However, the research suggests that there are numerous 
barriers that hinder PCPs from delivering evidence-based care to breast cancer survivors. The 
purpose of this project was to answer the following research question: what are the barriers that 
PCPs encounter in providing breast cancer survivorship care in the primary health care setting to 
women who have completed active cancer treatment in Canada? To answer this question a 
comprehensive review of the literature was conducted. The findings of this integrative review 
demonstrated provider-related barriers and system-related barriers linked to knowledge deficits, 
attitudes, workload demands, and perceived suboptimal oncologist support. Key strategies and 
recommendations to overcome these barriers were examined and discussed in order to improve 
the care of breast cancer survivors in the primary health care setting.  
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The most common cancer impacting women worldwide is breast cancer (Canadian 
Cancer Society, 2017). In Canada, this disease accounts for 25% of all cancer diagnoses among 
women (Canadian Cancer Statistics Advisory Committee, 2018). Due to earlier recognition and 
advances in cancer treatment the prevalence of breast cancer survivors is increasing. According 
to the Canadian Cancer Society (2019b), 88% of women who are diagnosed with breast cancer 
have a five-year relative survival rate, with only 23 deaths per every 100,000 diagnoses in 
Canada. Moreover, mortality rates of breast cancer have decreased by more than 44% since its 
peak in 1986 (Canadian Cancer Statistics Advisory Committee, 2018). The increasing number of 
breast cancer survivors presents a positive yet challenging disposition to Primary Care Providers 
(PCPs) in Canada, including Nurse Practitioners (NPs) and physicians, due to their responsibility 
to provide breast cancer survivorship care (Chopra & Chopra, 2014; Cooper, Loeb, & Smith, 
2010; Smith, Wai, Alexander, & Singh-Carlson, 2011).  
Survivorship is best supported by PCPs in primary health care settings because it is a 
phase in the cancer care trajectory that focusses on quality of life after completing specialized 
cancer treatment, until recurrence or end of life (Institute of Medicine [IOM], 2006). 
Furthermore, due to the increasing burden of breast cancer survivors on the tertiary cancer 
centres and the shortage of cancer specialists in Canada (Aju, 2018), survivors are discharged by 
their oncologists back to their PCPs soon after completion of active cancer treatment (Cooper et 
al., 2010; Del Giudice, Grunfeld, Harvey, Piliotis, & Verma, 2009; Smith et al., 2011). PCPs are 
essential to improving health outcomes for breast cancer survivors through their critical role in 
the survivorship phase of the cancer care trajectory.  
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Breast cancer survivorship care is complex and requires a high degree of knowledge and 
expertise concerning the impacts that breast cancer and its treatment can have on survivors, and 
the guidelines and recommendations addressing such impacts. The landmark report From Cancer 
Patient to Cancer Survivor: Lost in Transition (IOM, 2006), was one of the first documents to 
identify the unique needs of cancer survivors and provide standards of care for this population in 
relation to the following components: prevention, surveillance, intervention, and coordination. 
Since the release of this report, evidence-based guidelines have been created based on its 
foundational standards of care in order to assist PCPs in delivering breast cancer survivorship 
care. Although evidence-based guidelines are in place, research suggests that there are numerous 
factors hindering PCPs from delivering survivorship care based on these guidelines (Chopra & 
Chopra, 2014; Dawes et al., 2015; Kantsiper et al., 2009; Luctkar-Flude, Aiken, McColl, & 
Tranmer, 2015b; Smith, Murchison, Singh-Carlson, Alexander, & Wai, 2015). Acknowledgment 
of issues pertaining to the PCPs’ ability to deliver evidence-based breast cancer survivorship 
care, and identification of solutions to mitigate these barriers are imperative as inadequate care 
jeopardizes the health, wellness, and outcomes of breast cancer survivors.    
There is a lack of overall knowledge of the multifaceted barriers affecting the delivery of 
breast cancer survivorship care in the primary health care setting, with no existing study that 
captures a holistic representation of this problem. Without clearly identifying and analyzing the 
barriers to care, it is impossible to fully appreciate the extent of the issue in Canada. I speculate 
that a synthesis of the existing research may help to identify key strategies to overcome barriers 
to breast cancer survivorship care in the primary health care setting.  
In light of the magnitude of the issue outlined, this integrative review aims to identify the 
barriers that PCPs experience that influence the provision of evidence-based breast cancer 
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survivorship care in the primary health care setting to women following active cancer treatment, 
and to explore strategies to overcome these barriers. Choice of method for conducting the 
integrative review was guided by the following research question: what are the barriers that PCPs 
encounter in providing breast cancer survivorship care in the primary health care setting to 
women who have completed active cancer treatment in Canada? To address this question, 
literature relevant to the background and context will first be explored. Following this, the 
methods and findings of this integrative literature review will be presented. By exploring existing 
barriers to the provision of breast cancer survivorship care, it will be possible to identify 
strategies to overcome these barriers. By facilitating the provision of evidence-based breast 

















Background and Context 
 Prior to conducting the integrative review, it is vital to first recognize pertinent 
background information that informs the issue, context, and boundaries of the review itself. 
Thus, the following sections of this chapter will summarize the essential data providing the 
foundation for commencing the integrative review. This will include an overview of the 
epidemiology, pathophysiology, diagnosis, and treatment of breast cancer, as well as pertinent 
information regarding breast cancer survivorship. 
Breast Cancer 
Epidemiology. In Canada, approximately one in eight women will develop breast cancer 
in their lifetime (Government of Canada, 2017).  This means that out of an estimated 18,500,873 
females in Canada (Statistics Canada, 2018), approximately 2,312,609 women will have, do 
have, or already had this disease. According to the Canadian Cancer Statistics Advisory 
Committee (2018), the five-year relative survival rates for breast cancer vary depending on 
which stage of cancer one has, with only 22% survival for the latest stage of cancer (stage IV) 
and almost 100% survival for the earliest stage of cancer (stage I). With that being said, between 
2011 and 2015 more than 80% of Canadian women who were diagnosed with breast cancer had 
stage I or II and less than 5% had stage IV (Canadian Cancer Statistics Advisory Committee, 
2018). The number of women diagnosed in the early stages of breast cancer could explain why 




Pathophysiology. Anatomically, the breast overlies the pectoralis major muscle and is 
composed of glandular tissue including ducts and lobules, as well as connective tissue and fatty 
tissue (Kerr, Haller, Velde, & Baumann, 2016) as reflected in Figure 1. 
Figure 1 Anatomy of the Breast 
 
From iStock, by Getty Images, 2019. Copyright 2019 by Getty Images. Reprinted with 
permission.  
 
 The most common forms of breast cancer develop in the epithelial cells lining the ducts 
or lobules of the breast (Kosir, 2018). When malignant cells are confined to the ducts or lobules 
the cancer is classified as noninvasive and referred to as Ductal Carcinoma In Situ (DCIS) or 
Lobular Carcinoma In Situ (LCIS) (Kosir, 2018). Whereas, when malignant cells spread to the 
stromal cells or tissue outside the ducts or lobules or through the regional lymph nodes the 
cancer is classified as invasive. When the malignant cells have spread to other areas of the body, 
the breast cancer is considered both invasive and metastatic.  
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 Hormones can often play a role in the pathophysiology of this disease and are important 
biomarkers for the classification of breast cancer. Estrogen Receptors (ERs) and Progesterone 
Receptors (PRs) can be found in both normal cells and malignant cells of the breast, however 
they tend to be overexpressed in malignant cells (Kerr et al., 2016). The ERs and PRs can 
promote cellular growth and division of breast cancer when estrogen and progesterone hormones 
bind to the sites. Approximately two-thirds of postmenopausal women diagnosed with breast 
cancer have an ER-positive (ER+) tumor, which is associated with better prognosis than breast 
cancers that are ER-negative (ER-) (Dai, Xiang, Li, & Bai, 2016). This is because these types of 
tumors are much more likely to respond to hormonal therapy, which is discussed further in the 
treatment section. 
 Proto-oncogenes, which normally regulate cellular growth and differentiation, can be 
implicated in breast cancer as well. When mutated or altered, proto-oncogenes can become 
oncogenes such as the Human Epidermal Growth Factor Receptor 2 (HER2) and can cause 
unregulated growth of breast cancer (Kerr et al., 2016). HER2 over-expression is associated with 
more aggressive forms of breast cancer as well as higher recurrence rates and occurs in 
approximately 20% of invasive ductal breast cancers (Dai et al., 2016). 
Screening. Appropriate screening methods support early detection of breast cancer in 
women. The Canadian Task Force on Preventative Health (2018b) recommends that average risk 
women ages 50 to 74 receive routine screening with mammography every two to three years. It 
is no longer recommended that average risk women ages 40 to 49 receive routine 
mammography, as the harms have been found to outweigh the benefits in this age group. For 
those women ages 40 to 74 who have a high risk of acquiring breast cancer (see Table 1), annual 
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screening mammograms are recommended (BC Cancer, 2018;1 Canadian Task Force on 
Preventative Health, 2018b).  
Table 1 High Risk Women for Breast Cancer 
High Risk Women for Breast Cancer  
• Personal history of breast cancer 
• Family history of breast cancer 
• Known BRCA1 or BRCA2 gene mutations 
• Known first-degree relative with BRCA1 or BRCA2 gene mutations 
• History of radiation therapy to chest before 30 years of age or within the past eight 
years 
(Adapted from Canadian Task Force on Preventative Health, 2018b) 
Breast Self Exams (BSE) by the individual and routine Clinical Breast Exams (CBE) by 
the PCP are no longer recommended to screen for breast cancer in asymptomatic women with no 
prior history of this disease, as the evidence supports that these strategies do not reduce breast 
cancer mortality or all-cause mortality (Canadian Task Force on Preventative Health, 2018a). 
Rather, BSE’s have been associated with increased harm from a breast biopsy of benign origin 
(Canadian Task Force on Preventative Health, 2018a). It is important however, for the PCP to 
conduct CBEs on women who present with concerns regarding abnormal breast changes 
(Canadian Task Force on Preventative Health, 2018b).  
 Diagnosis. The process of diagnosing breast cancer often begins after a lump or mass has 
been detected in the breast either during a BSE, a CBE, or a mammogram (Canadian Cancer 
Society, 2018a). After lump detection, further physical exams and imaging studies may be 
conducted in order to differentiate between benign lumps not requiring further investigation, or 
lumps with a high suspicion of malignancy. For suspected malignancy, a biopsy of the lump’s 
tissue is required in order to make a definitive diagnosis of breast cancer. The form of biopsy 
 
1 The BC Cancer Agency’s name was changed to BC Cancer in 2017 (BC Cancer Foundation, 2017) 
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used depends on whether the lump is palpable or non-palpable and can include: Fine Needle 
Aspiration (FNA) biopsy, core needle biopsy, stereotactic core biopsy, wire localization biopsy, 
surgical biopsy, or punch biopsy (Canadian Cancer Society, 2018). A Sentinel Lymph Node 
Biopsy (SLNB) can also be done in order to determine if the breast cancer has spread to the 
lymph nodes. Rather than removing all of the axillary lymph nodes draining the breast tissue, a 
SLNB only dissects the first lymph node in the axillary chain draining fluid away from the tumor 
site (Zahoor et al., 2017). An SLNB helps with staging the disease, as well as can prevent 
increased morbidity caused by an Axillary Lymph Node Dissection (ALND).  
 Anatomical staging of breast cancer is done according to the tumor-nodes-metastasis 
(TNM) classification system, which evaluates the size of the tumor, the extent of regional lymph 
node involvement, and spread of metastases (American Joint Committee on Cancer [AJCC], 
2018). Broadly speaking, there are five stages of breast cancer, including stage 0 (Carcinoma in 
situ) followed by stages I (early stage breast cancer) to IV (metastatic breast cancer) (Canadian 
Cancer Society, 2019a). In addition to the TNM categories, there are other staging factors that 
must be taken into account when determining both prognosis and viable treatment options for 
individuals with breast cancer, including ER/PR and HER2 status, and tumor grade (AJCC, 
2018). The tumor grade refers to how abnormal the tumor’s tissue and cells looks under a 
microscope, and is usually graded on a scale of one to three, with one looking more like normal 
tissue than three. Oncogenomic tests, including the Oncotype Dx Assay2 test for example, may 
also be considered during the cancer staging process to further determine prognosis and whether 
or not one may benefit from certain treatments (AJCC, 2018).  
 
2 The Oncotype Dx Assay test examines several cancer-related genes in tumor tissue that help determine how likely 
the cancer is to metastasize or recur, as well as how likely it will respond to certain systemic therapy options. 
16 
 
Women with metastatic breast cancer, also known as stage IV breast cancer, are rarely 
discharged back to their PCP due to the incurable state of this stage of cancer, as well as the 
complexities associated with wide-spread disease (BC Cancer, 2017a). In staying aligned with a 
primary health care context, the remainder of this chapter will focus on breast cancer that is 
eligible for curative-intent treatment options that have potential to lead to cancer remission 
and/or cure.  
Treatment. There are numerous different treatment options for women with breast 
cancer in Canada including a combination of surgery, radiation therapy, and systemic therapy. 
Treatment regimens are chosen according to: evidence-based provincial policies; stage and 
biomarker profile of cancer; risk-benefit ratio; and patient characteristics such as age, co-
morbidities, life-expectancy, menopausal status, and personal preferences (BC Cancer, 2016; 
Kerr et al., 2016). Each of these treatment options will be summarized in the following 
paragraphs. However, it is important to keep in mind that cancer treatment is constantly evolving 
based on the latest evidence.   
Surgery. The key goal of surgery for breast cancer is to attain local control of the disease 
(Kerr et al., 2016). There are two main types of surgeries for breast cancer including Breast 
Conserving Surgery (BCS) and a mastectomy. BCS is appropriate for women with early stage 
disease (stage I or II) and depending on the size and location of the tumor the BCS can either 
consist of a lumpectomy, wide local excision (WLE), partial mastectomy, or segmental 
mastectomy (BC Cancer, 2016; Rahman, 2011). The surgical technique chosen for BCS is based 
on not only what will achieve local tumor control, but also on what will allow for the most 
esthetically pleasing result (Rahman, 2011). Adjuvant radiation therapy is often recommended 
for those who have BCS in order to reduce the risk of ipsilateral breast cancer recurrence (BC 
17 
 
Cancer, 2016; Rahman, 2011). Conversely, a Total Mastectomy (TM) is a surgical technique that 
removes the entire breast including the lining over the pectoralis major muscle but does not 
include an ALND. A TM is also an option for those with early stage breast cancer who have a 
contraindication to BCS including: multicentric disease, prior radiation therapy to the chest wall, 
poor cosmetic or clinical outcome with BCS, or pregnancy that prevents adjuvant radiation 
therapy (BC Cancer, 2016; Rahman, 2011). A Modified Radical Mastectomy (MRM) is the same 
as a TM, only axillary lymph nodes are also removed (Kerr et al., 2016).  
 Radiation Therapy. Radiation therapy can have a vital role in treating breast cancer in 
combination with other treatment modalities or on its own and is indicated for women with 
invasive breast cancer that is node-positive or high-risk cases that are node-negative (BC Cancer, 
2017c). Radiation therapy works by damaging the tumor cells either by directly inducing 
ionization on the tumor or by indirectly producing free radicals from ionization (Basker, Dai, 
Wenlong, Yeo, & Yeoh, 2014). The rationale of this treatment modality is based on evidence 
that malignant cells are more at risk of DNA damage than normal cells because they rapidly 
proliferate (Baskar et al., 2014). Radiation can be delivered outside of the body through external 
beam radiation therapy, or radioactive material can be delivered internally through brachytherapy 
or systemic radiation therapy (Basker et al., 2014). The goal of radiation therapy is to have the 
most impact on tumor control, while reducing the damage to normal cells (Basker et al., 2014).  
Systemic therapy. As opposed to surgery or radiation therapy which target cancer cells in 
a localized area, systemic management of breast cancer can eliminate malignant cells that are 
located anywhere in the body. Treatment modalities that are considered systemic therapy include 
hormonal therapy, chemotherapy, and targeted therapy (BC Cancer, 2013). Systemic treatment 
regimens are influenced by the aforementioned list of factors discussed for any cancer treatment, 
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as well as the following three broad characteristics: hormone receptor positive and HER2 
negative cancers; HER2 positive cancers; and triple negative cancers (ER-PR-HER2-) (BC 
Cancer, 2013).  
For women with ER+ or PR+ breast cancer, five years of hormone therapy is 
recommended based on a significant survival benefit of such treatment (BC Cancer, 2013). For 
pre-menopausal women the hormone treatment of choice is tamoxifen, whereas in post-
menopausal women an aromatase inhibitor and/or tamoxifen is considered (BC Cancer, 2013). 
For early stage breast cancer, chemotherapy is considered if any of the following characteristics 
are present: tumor size of over two cm; lymphatic and/or vascular invasion; tumor grade of three; 
weak hormonal receptor expression; or node positive findings (BC Cancer, 2013). In addition to 
these characteristics, oncogenomic tests are also starting to be utilized to identify the usefulness 
of chemotherapy. One noteworthy clinical trial underway for women with breast cancer is the 
Trial Assigning Individualized Options for Treatment (TAILORx) (National Cancer Institute, 
2018). The trial’s initial findings established that chemotherapy does not provide a significant 
survival benefit to women with early stage hormone receptor-positive, HER2-negative, node 
negative breast cancer that have a low or intermediate risk of recurrence based on their Oncotype 
Dx Assay (National Cancer Institute, 2018). Trial’s such as this highlight the importance of 
personalizing cancer treatment to each individualized patient. 
There are several adjuvant chemotherapy drugs available for women with breast cancer 
who may benefit from this treatment modality and in general, most regimens include four to six 
months of treatment (BC Cancer, 2013). A treatment regimen for those with HER2+ breast 
cancer is usually a combination of chemotherapy, a HER2 targeted therapy called trastuzumab, 
and hormone therapy if indicated (BC Cancer, 2013). On the contrary, triple negative breast 
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cancers do not benefit from hormone or targeted therapy, therefore chemotherapy is strongly 
recommended (BC Cancer, 2013). Chemotherapy is occasionally given as Neoadjuvant Therapy 
(NAT) for breast cancer, which means that it is given prior to surgery. Most commonly, NAT is 
considered for patients with inoperable disease or large tumors because it can decrease the size 
of the tumor and render it operable (BC Cancer, 2017b). In the past, further neoadjuvant 
chemotherapy was not recommended if residual disease was still present after the completion of 
this treatment (Zujewski & Rubinstein, 2017). However, findings of a clinical trial called 
CREATE-X found that adjuvant capecitabine3 improves survival outcomes in women with early 
stage, HER2-negative breast cancer who did not receive a complete response with neoadjuvant 
chemotherapy (Zujewski & Rubinstein, 2017). Due to ongoing changes in recommendations for 
cancer treatment, it is important for health care providers to remain up-to-date.  
After active cancer treatment ends, cancer survivorship as a phase in the cancer care 
trajectory follows. It is important to mention that active treatment, such as surgery, radiation, 
chemotherapy, and/or targeted therapy, refers to treatments that have an immediate effect on 
breast cancer control, and involve tertiary health care, whereas treatment that can be prescribed 
and followed by a PCP such as hormonal therapy, is not considered active treatment within a 
cancer context. Therefore, the breast cancer survivorship experience as it relates to post-active 
treatment can still include hormonal therapy such Tamoxifen and/or an aromatase inhibitor.   
Breast Cancer Survivorship  
Conceptual definition. In order to understand the parameters inherent to this integrative 
review, it is vital to have a clear and consistent definition of cancer survivorship. Conceptual 
clarity helps create a common language for discussing breast cancer survivorship care, and in 
 
3 Capecitabine is an oral chemotherapy drug used to treat certain cancers including breast cancer.  
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doing so will better guide the outcomes of this integrative review. Therefore, the next part of this 
paper will summarize the concept of cancer survivorship and how it will be explored within the 
parameters of this study.  
Firstly, cancer survivorship is a concept that was created to embody the experience of 
cancer survivors across the cancer care trajectory, which spans from diagnosis until the end of 
one’s life (Miller, Pandey, Jain, & Mehta, 2015; National Coalition for Cancer Survivorship 
[NCCS], 2014; Ness et al., 2013; Oliveira, Araujo, Conceição, & Zago, 2015; Rowland, 2008; 
Wronski, 2015). Consequently, once one is diagnosed with cancer, cancer survivorship as a 
process of living does not end. For the purpose of this integrative review breast cancer 
survivorship will be explored in the time span after active cancer treatment is complete until end 
of life or cancer recurrence, which is when a primary health care context is the most relevant.  
The definition and application of cancer survivorship is most widely used to discuss an 
experience that is exclusive to the individual with cancer, not their family, friends, or caregivers 
(Bell & Ristovski-Slijepcevic, 2013; Burkett & Cleeland, 2007; Dirven, van de Poll-Franse, 
Aaronson, & Reijneveld, 2015; Khan, Rose, & Evans, 2012; Oliveira et al., 2015; Wronski, 
2015; Zebrack, 2015). The exclusivity, in part, is due to the fact that anyone other than the 
individual with cancer will not experience the negative and positive elements intrinsically tied to 
having cancer and receiving cancer treatment. Therefore, when breast cancer survivorship is 
discussed in this integrative review it pertains only to women diagnosed with breast cancer.   
Lastly, cancer survivorship is not only exclusive to the individual with cancer, but also 
unique to each cancer survivor. It is a multifaceted concept that requires deconstruction and 
reflection of the contexts inherent to the cancer survivor which include: sex, age, ethnicity, type 
of cancer, type of cancer treatment, prognosis of disease, comorbidity, culture, country, health 
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care system, support systems, personal characteristics and socioeconomic status (Bell & 
Ristovski-Slijepcevic, 2013; Dirven et al., 2015; Khan et al., 2012; Miller et al., 2015; Zebrack, 
2105). With that being said, the needs of cancer survivors are diverse and greatly dependent on 
their individual circumstances.  
Needs of breast cancer survivors. After the completion of active cancer treatment, the 
needs of breast cancer survivors are multifaceted. The cancer and its treatment can cause 
numerous acute, chronic, late, and/or permanent effects spanning physical, emotional, mental, 
and social domains of health (IOM, 2006). Physical toxicities from cancer treatment may extend 
from acute issues to chronic issues and often include pain, lymphedema, fatigue, sleep 
disturbances, and peripheral neuropathy (Cheng, Devi, Wong, & Koh, 2014).  In addition to 
physical ailments, breast cancer survivors can also experience emotional distress, anxiety, and 
depression related to fear of recurrence, body image issues, and adjusting to a new normal 
(Fiszer, Dolbeault, Sultan, & Bredart, 2014). Mentally, women report they struggle with feelings 
of abandonment after cancer treatment ends due to the lack of continuity of care, and inadequate 
supportive services in place (Cheng, Cheng, Wong, & Koh, 2017; Olson et al., 2014). Each of 
these components also affect social functioning in regards to relationships with family and 
friends and returning to work or the activities one did before being diagnosed with breast cancer.  
It is important to remember that the cancer experience does not end once active treatment 
is complete. A groundbreaking study of 30,000 Canadians who had been diagnosed with cancer, 
and were either living with or beyond the disease, reported that issues caused by the side effects 
of cancer and its treatment are not being adequately addressed (Canadian Partnership Against 
Cancer, 2018). It is also vital to acknowledge the unique experience of a breast cancer survivor. 
In a study done by Burg et al. (2015), breast cancer survivors reported the most unmet needs out 
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of six different types of cancer. Women with breast cancer require increased access to 
survivorship care, more emotional support, and better education regarding health promotion and 
disease prevention in order to improve the quality of their lives after active cancer treatment ends 
(Cheng et al., 2014; Cheng et al., 2017; Fiszer et al., 2014; Olson et al., 2014;). In order to 
address these gaps, there may have to be a change in current models of breast cancer 
survivorship care.  
Models of care. Current breast cancer survivorship care models differ based on the 
following: type of provider delivering care; type of care setting; and overall purpose of the 
program (Halpern et al., 2015). Providers used in survivorship care models include physicians, 
NPs, oncologists, and/or oncology nurses, in either out-patient primary health care settings or 
specialized tertiary cancer centres (Halpern et al., 2015). It is important to note that the term 
physician is referring to a general practitioner. Although oncologists are considered physicians 
with a specialty in cancer care, they will only be referred to as oncologists in this integrative 
review in order to avoid confusion between these providers. Key models of care can be described 
as a PCP-led care model, oncologist-led care model, shared-care model, or specialized clinic 
model. To clarify, the shared-care model as it relates to cancer survivorship care is provided by 
the oncologist and the PCP who both have equal responsibility in such care (American Society of 
Clinical Oncology [ASCO], 2019). The specialized clinic model refers to care that is provided to 
cancer survivors in a specialized clinic and is led by a NP and/or physician who have advanced 
cancer survivorship training (Halpern et al., 2015). Purposes of survivorship care models are 
based on the program in which they are delivered, such as those that focus on cancer survivors’ 
transition from tertiary health care to primary health care after the completion of active treatment 
(Halpern et al., 2015). While there are varied approaches for cancer survivorship care programs, 
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they each aim to improve the quality of life of cancer survivors through evidence-based, best 
practice care delivery.  
Primary health care. Although there is no evidence to suggest one survivorship care 
model is superior to another (Halpern et al., 2015), the literature does support breast cancer 
survivorship care being delivered in a primary health care setting. Sussman et al. (2017) found 
that after the completion of active cancer treatment it is a practical and safe option for breast 
cancer survivors to be discharged from specialist-led care within a tertiary health care setting to 
PCP-led care within a primary health care setting (Sussman et al., 2017). In fact, it has been 
found that patient satisfaction with breast cancer survivorship care is far greater in a primary 
health care setting versus a tertiary health care setting (Sussman et al., 2017), which further 
supports a PCP-led care model.  
Primary care providers. It is essential to understand the similarities and differences 
between the two main PCPs in Canada, NPs and physicians, in order to understand how they can 
support the delivery of breast cancer survivorship care in the primary health care setting. Both 
NPs and physicians are autonomous health care professionals who can diagnose and treat 
medical conditions and diseases, order and interpret diagnostic tests, prescribe pharmacotherapy, 
and perform medical procedures within their legislated scope of practice outlined by their 
provincial regulatory bodies (Canadian Nurses Association, 2018; College of Physicians and 
Surgeons of British Columbia, 2018). It is important to note that NPs’ and physicians’ scopes of 
practice differ between provinces, with some legislating wider scopes of practice than others. 
A key difference between NPs and physicians in Canada is their educational 
backgrounds. NPs must first obtain their Bachelor of Nursing degree and gain two to five years 
of full-time nursing experience prior to applying to a nurse practitioner program, which is 
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delivered at a master’s level. Whereas, a physician goes to medical school to obtain an 
undergraduate degree in medicine and then following this, requires at least two years of hands on 
experience in a residency program depending on the field in which they choose to specialize. 
Even with differing educational backgrounds, the evidence suggests that NPs and physicians 
provide comparable care that leads to equivalent health outcomes of patients in the primary 
health care setting (Horrocks, Anderson, & Salisbury, 2002; Stanik-Hutt et al., 2013).  
Evidence-based guidelines. The most current evidence-based Canadian national 
guidelines for breast cancer survivorship care within a primary health care setting were created 
by Luctkar-Flude, Aiken, McColl, and Tranmer (2015a) and Sisler, Chaput, Sussman, and 
Ozokwelu (2016). In addition to national guidelines, it is important to note that most provinces in 
Canada have created their own guidelines (Alberta Health Services, 2015; BC Guidelines, 2013). 
Each of these guidelines fall in line with the landmark report by the IOM (2006), that states 
survivorship care should include four components: prevention of recurrent and/or new cancers, 
as well as late effects of cancer; surveillance for recurrent and/or new cancers and assessment of 
physical and psychosocial effects of cancer; intervention for long-term effects of cancer and/or 
cancer treatments; and coordination and/or referral between the interdisciplinary team to confirm 
all health care needs are being met. To summarize, these guidelines include recommendations to 
help patients improve their health status and prevent cancer recurrence such as exercise, 
nutrition, weight management, and other aspects of health promotion. They also comprise 
surveillance recommendations including imperative health assessments to be performed and 
investigations to be ordered at specific intervals in time. Moreover, the guidelines highlight 
screening and treatment recommendations for physical and psychological consequences of breast 
cancer and its treatment. Lastly, the guidelines discuss recommendations to utilize other 
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interdisciplinary team members as warranted, as well as encourage the use of survivorship care 
plans and/or discharge letters from oncologists to ensure all health care needs of breast cancer 
survivors are being met in the primary health care context. These guidelines can be used to direct 
all activities to be implemented for breast cancer survivorship care.  
The next chapter will describe the literature search strategy used to answer the question: 
what are the barriers that PCPs encounter in providing breast cancer survivorship care in the 
primary health care setting to women who have completed active cancer treatment in Canada? 
The purpose of this literature search was to identify a comprehensive representation of the 
barriers affecting the delivery of evidence-based breast cancer survivorship care in the primary 
health care setting. The findings following a critical analysis of the literature were synthesized 




























Comprehensive recognition of a problem, such as barriers to the delivery of breast cancer 
survivorship care, is a necessary first step that must be taken before effective upstream solutions 
can be identified. The following sections of this chapter will provide an overview of the research 
methods utilized to answer the main research question of this integrative review.  
An integrative review method was chosen as it combines published quantitative, 
qualitative, and mixed-methods research in order to provide a more comprehensive 
understanding of a research problem (Whittemore & Knafl, 2005). This form of review method 
has the ability to present strong research evidence to inform clinical practice in primary health 
care and support policy development (Whittemore & Knafl, 2005). However, in order for 
integrative reviews to be considered high quality evidence, a structured process indicating 
systematic and rigorous methods of the literature search, appraisal and analysis are necessary. 
With the intention of better guiding a systematic research process the author utilized 
methodologies from Health Evidence (2009), Critical Appraisal Skills Programme tools 
([CASP], 2018), Torraco (2005), and Whittemore and Knafl (2005) for this integrative review.  
Prior to conducting the literature search, eligibility criteria were developed in order to 
determine relevant sources of literature that focussed on the research question. Due to the 
dramatic changes that have occurred in cancer treatment and care over the last decade, sources of 
research were limited to articles published between July 2008 and July 2018. Only peer-reviewed 
articles published in English were included in order to ensure quality and enable review of such 
sources. Since the focus of this proposed integrative review is on PCPs, including NPs and 
physicians, literature sources had to be relevant to those disciplines. However, articles were not 
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excluded if they also pertained to other care providers as long as the data pertaining to each 
discipline were separately obtained and documented in the study. In addition, since the context of 
the review is primary health care, literature had to be focussed on care in this setting. As the 
population of interest is for those patients with breast cancer, the literature was limited to studies 
that focussed on 50% or more of this disease group. For example, inclusion was granted for 
studies pertaining to breast cancer survivors and one more cancer group (i.e. colorectal cancer 
survivors). In order for the results of this integrative review to be generalizable to diverse 
populations, inclusion was permitted for literature that pertained to women of all ages with breast 
cancer. The main reasons for not including male breast cancer survivors in this review is because 
breast cancer survivorship care is highly gender-informed, and less than 1% of all breast cancer 
occurs in men (Canadian Cancer Society, 2018). In addition, this review only included articles 
related to the delivery of breast cancer survivorship care after the completion of active cancer 
treatment, due to this research having a primary health care focus. Lastly, studies included in the 
review had to be conducted within North America, including Canada and the United States. The 
reason for not including all areas of the world is due to the diversity that exists between patient, 
provider, and system factors in other countries, and therefore the degree of variables an 
international scope would introduce within the integrative review. These inclusion and exclusion 




Table 2 Inclusion and Exclusion Criteria 
Inclusion and exclusion criteria 
Inclusion 
• Years of publication: 2008 – 2018 
• Publication language: English 
• Peer-reviewed articles 
• Data on PCPs (NPs and/or physicians) 
with or without separate data on other 
disciplines (i.e. oncologists, nurses) 
• Primary health care setting 
• Focus on ≥ 50% breast cancer 
survivorship 
• Female breast cancer survivors   
• Breast cancer survivors who have 
completed active cancer treatment 
(excluding hormonal therapy) 
 
• Location: Studies done in North 
America (including Canada and 
United States) 
Exclusion 
• Publication older than 2008 
• Non-translated articles 
• Non-reviewed articles 
• No data on PCPs (NPs and/or 
physicians) with only data on other 
disciplines (i.e. oncologists, nurses) 
• Secondary or tertiary care setting 
• Focus on < 50% breast cancer 
survivorship 
• Male breast cancer survivors 
• Breast cancer survivors who continue 
to receive active treatment including 
surgery, radiation therapy, and/or 
systemic therapy 
• Location: Studies done outside of 
North America  
Literature Search 
 The search strategy for this integrative review was conducted in three stages and for that 




Figure 2 Flow Diagram of Search Process 
 
(Adapted from Health Evidence, 2009) 
Stage one. The first stage of the literature search involved gathering all potentially 
relevant articles from electronic databases. With a focus in nursing, medicine, and other health 
disciplines, the following databases were searched as they contained the most relevant literature 
for the purpose of the review: Cumulative Index of Nursing and Allied Health Literature 
(CINAHL), Medline, and PubMed. The Journal of Cancer Survivorship, The Nurse Practitioner, 
Canadian Family Physician, and Canadian Medical Association Journal were identified as 
relevant sources of literature as well, and were each indexed in the utilized electronic databases. 
Each database was searched with a limit to peer-reviewed articles written in English and 
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published between July 2008 and July 2018. In order to keep the literature search focussed and 
relevant to the research question, the following search terms were used in combination: “Nurse 
Practitioners,” “Physicians,” “Primary Health Care,” “Transitional Care,” “Oncologic Care,” 
“Health Care Delivery,” “Breast Neoplasms,” and “Cancer Survivors.” In addition to the search 
terms, the following keywords were used as well: “Breast Cancer Survivorship,” “Survivors of 
Breast Cancer,” “Breast Cancer Survivors,” “Survivorship care in Breast Cancer,” “Primary Care 
Provider,” and “Breast Cancer.” With the use of these search terms, keywords, and search 
limiters, the electronic databases yielded 3577 results including duplicates and non-relevant 
articles on July 31, 2018 (see Appendix B).  
In addition to the electronic databases, Google Scholar was used in order to increase the 
comprehensiveness of this integrative review, and to confirm saturation of the literature search. 
In this search strategy, specific keywords relevant to the integrative review were used including: 
“Nurse Practitioners,” “Physicians,” “Primary Care Providers,” and “Breast Cancer 
Survivorship.” More specificity in the search was required for Google Scholar in order to keep 
the search focussed and the results relevant. With use of the main search terms, Google Scholar 
yielded 452 results on August 1, 2018, including duplicates and non-relevant articles (see 
Appendix C).  
The search results were imported to EndNote reference management software. Using this 
software 2051 duplicates were identified from multiple sources, confirming data saturation, and 
leaving 1978 articles for review.  
Stage two. Stage two of the literature search process involved the exclusion of non-
relevant articles based on the aforementioned eligibility criteria. In this initial screening process 
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each article’s title and abstract were viewed. The author identified 158 potentially relevant 
results after this process was complete. 
Stage three. Stage three of the literature search process involved an assessment of the 
full document versions of each of the 158 articles for relevance and quality. According to Gray, 
Grove, and Sutherland (2017), all literature that meets eligibility criteria needs to be critically 
appraised for its strength of evidence to ensure high quality research is being used. With the use 
of the CASP tools (CASP, 2018) and Gray et al. (2017), a thorough appraisal was done on each 
study. Stage three identified 11 articles for use in the integrative review (see Appendix D) and 
excluded 147 articles that did not meet eligibility criteria or were not considered high quality 
evidence upon appraisal. 
Literature Analysis 
Critical analysis of the literature requires a thorough and unbiased examination of the 
main themes related to an issue and is imperative to produce strong research evidence in an 
integrative review (Torraco, 2005; Whittemore & Knafl, 2005). The literature analysis of this 
integrative review involved the data analysis method proposed by Whittemore and Knafl (2005) 
which consists of four phases including: 1) data reduction, 2) data display, 3) data comparison, 
and 4) conclusion drawing and verification. Conducting a literature analysis in separate stages 
can improve the internal validity of a review study by providing a more systematic approach. 
Data reduction, display, and comparison. In the first phase of the analysis process, the 
data reduction phase, literature was divided into subgroups based on type of study (i.e. 
descriptive, qualitative, and mixed studies) as recommended by Whittemore and Knafl (2005) as 
a strategy to facilitate analysis. Since the focus of the review is on PCPs and breast cancer 
survivors, only data pertaining to NPs and/or physicians and this cancer survivor group were 
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extracted from each article. This data was then compiled into a literature review matrix table that 
identified the same pertinent data about each study separately (see Appendix D). This data 
display method allowed the author to compare the literature in a structured, organized manner, 
and subsequently, identify themes.  
Conclusion drawing and verification. The final phase of the analysis process is to 
synthesize the information in order to provide integrated conclusions that answer the research 
question, therefore completing the review process (Whittemore & Knafl, 2005). After critical 
analysis of the literature, two overarching themes became evident related to barriers PCPs 
encounter in providing breast cancer survivorship care: provider-related barriers, and system-


















This integrative review explores the barriers that PCPs experience that influence the 
provision of evidence-based breast cancer survivorship care in the primary health care setting in 
Canada. The current chapter provides a synthesized analysis of the final cohort of 11 research 
studies reviewed for this integrative review to assist in answering the research question: what are 
the barriers that PCPs encounter in providing breast cancer survivorship care in the primary 
health care setting to women who have completed active cancer treatment in Canada? Although 
six of the 11 studies were conducted in the United States, the findings are relevant to the 
Canadian context as barriers to breast cancer survivorship care were consistent throughout the 
literature within Canada and the United States. It is from understanding issues pertaining to the 
PCPs’ ability to deliver breast cancer survivorship care, that solutions to mitigate these barriers 
can be identified.  
Analysis of Research Studies  
Descriptive studies. Six of the articles analyzed for this integrative review are classified 
as descriptive studies. Each of these studies utilized surveys to obtain quantitative data. Key 
findings obtained from these studies included PCPs’ preferences in breast cancer survivorship 
care models, PCPs’ confidence in providing care to breast cancer survivors, and PCPs’ 
knowledge of breast cancer survivorship care components. 
Potosky et al. (2011) conducted a quantitative cross-sectional study which compared 
views of primary care physicians and oncologists on the following topics: preferred breast cancer 
survivorship care models; perceptions of primary care physicians’ ability to deliver breast cancer 
survivorship care; self confidence in delivering breast cancer survivorship care; and cancer 
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surveillance practices. Of the 5275 providers randomly selected from the American Medical 
Association Physician Masterfile, 3596 individuals received a Survey of Physician Attitudes 
Regarding the Care of Cancer Survivors (SPARCCS) based on eligibility and willingness to 
participate. The surveys were mailed between March 2009 and December 2009, up to four times 
per non-respondent. This study had a good absolute response rate of 57.6% (Gray et al., 2017), 
with 1072 primary care physicians and 1130 oncologists (2202 participants).  
The findings of this study were clear and are highlighted in the narrative as well as 
display tables. Data on physicians’ preferred care models of breast cancer survivorship care 
included: 38% for shared-care model; 25% for oncologist-led care model; 22% for specialized 
clinic model; and 10% for a PCP-led care model. Although respondents least preferred a PCP-led 
care model, a majority of physicians (59%) “strongly” or “somewhat agreed” that they had the 
skills to provide breast cancer survivorship care related to the effects of the cancer and its 
treatment. In addition to this, 75% of physicians felt they had the skills to provide appropriate 
surveillance practices and half (51%) expressed that they were better suited to provide 
psychosocial support to breast cancer survivors than oncologists. In regards to confidence levels, 
only 40% of physicians felt confident in their ability to detect recurrent disease, 23% to manage 
physical effects of cancer and its treatment, and 41% to manage psychosocial outcomes of cancer 
and its treatment. Data concerning surveillance care practices highlighted that a significant 
proportion of physicians in the study recommended more surveillance tests than advised by the 
guidelines, suggesting a possible knowledge deficit.  
The greatest strength of this study is that the Masterfile enabled the authors to achieve a 
nationally representative sample, which supported results that are generalizable to a large 
number of primary care physicians. The use of the SPARCCS instrument to collect data was also 
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a strength of the study because it was developed using a modified Delphi approach, as well as 
pilot tested and revised, which increased its validity. The authors also measured for response 
bias, which was not found based on the participant versus non-participant characteristics. A 
weakness of the study is that data was collected in 2009, therefore the results may not be as 
pertinent today. For improved validity, current studies are needed to support Potosky et al.’s 
(2011) findings.  
For the purpose of this integrative review, the findings of this study offer insight into 
primary care physicians’ preference for a shared-care cancer survivorship model, as well as their 
lack of confidence in providing different components of breast cancer survivorship care. A key 
finding from this study is that although a majority of primary care physicians felt they had the 
skills to provide care to breast cancer survivors, they least preferred a care model allocating them 
sole responsibility of breast cancer survivorship care. In addition to this, even though three-
quarters of the participants felt they had the knowledge to conduct appropriate surveillance on 
breast cancer survivors, less than half of the same respondents felt confident in detecting 
recurrent disease and many deviated from recommended surveillance guidelines. Overall, this 
study found that many PCPs are uncertain about their ability to provide care to breast cancer 
survivors, and as such are lacking confidence in providing various components of breast cancer 
survivorship care. This study also suggests critical knowledge deficits in PCPs’ ability to care for 
breast cancer survivors. 
Cheung, Noone, Potosky, Virgo, and Stefanek (2013) performed a quantitative cross-
sectional study that aimed to evaluate how physician attitudes and self efficacy regarding breast 
cancer survivorship care relate to their preference for care models. The authors used data from 
the SPARCCS sent out in the original nationally representative study done by Potosky et al. 
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(2011). The sample size was less than the overall sample collected by Potosky et al. (2011), 
consisting of 938 primary care physicians and 1088 oncologists, because participant data was 
excluded if providers did not answer the question relating to preferred cancer survivorship 
model, or if they chose more than one preference.  
The results of this study were interesting. Data on physicians’ preferred care models of 
breast cancer survivorship care included: 40% for shared-care model; 26% for oncologist-led 
care model; 18% for a specialized clinic model; and 10% for PCP-led care model. Similar to 
Potosky et al.’s (2011) findings, only a small number of physicians felt confident in monitoring 
for cancer recurrence (34%), and late and long-term effects of cancer and its treatment (19%). 
However, over half of the physicians (57%) “strongly” or “somewhat” agreed that they had the 
knowledge to provide breast cancer survivorship care, with 74% reporting an ability to detect 
recurrent cancers, and 50% reporting an ability to provide psychosocial support. Yet, only 32% 
of physicians felt they should be solely responsible for this type of care. The data focussed on by 
Cheung et al. (2013) included predictors of PCPs’ preference for breast cancer survivorship care 
models. Those physicians who were ≥40 years old, were more likely to prefer an oncologist-led 
care model for survivorship care. However, those with greater cancer surveillance experience 
had significantly higher odds of supporting a PCP-led care model or shared-care model more 
than an oncologist-led care model. Not surprisingly, those respondents who felt PCPs should be 
responsible for breast cancer survivorship care, were more likely to support a PCP-led care 
model. 
The main strength of this study is the generalizability of the results based on the 
nationally representative sample. Even though the study was based on secondary data from 
Potosky et al. (2011), the results of the study still proved to be useful since the key aim of this 
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study was different than Potosky et al.’s (2011) and new analyses were conducted on the data. A 
limitation of this study is the lack of transparency in the findings, as the authors reported data on 
PCPs’ preferences for PCP-led care models and shared-care models as one care model option 
(51%) in the main body of the article. Therefore, although significant, physicians least preferring 
a PCP-led model of breast cancer survivorship care was not discussed. Fortunately, the authors 
did disclose data on preferences of these care models separately in the appendix. 
The findings of this study are useful in answering the research question, as they garner 
further insight into PCPs’ preferences for breast cancer survivorship care models, and new data 
on predictors of such preferences. An important piece of data distinctive to Cheung et al.’s 
(2013) study is that PCPs with prior or ongoing experience with breast cancer survivors, and who 
felt they should be responsible for breast cancer survivorship care, were significantly more likely 
to support a PCP-led care model or shared-care model versus an oncologist-led care model. 
Therefore, this study suggests physician knowledge and attitudes can facilitate or impede the 
provision of evidence-based breast cancer survivorship care in the primary health care setting.    
Virgo, Lerro, Klabunde, Earle, and Ganz’s (2013) quantitative cross-sectional study 
aimed to examine and compare barriers perceived by oncologists and primary care physicians 
related to caring for breast cancer survivors that are five years post active cancer treatment. The 
authors utilized the nationally representative survey data obtained by Potosky et al. (2011) to 
examine 10 self-reported barriers of oncologists and primary care physicians related to delivering 
cancer survivorship care. The study sample included 2202 participants as per Potosky et al. 
(2011).  
The study offered significant findings. However, it is important to mention that some 
findings were excluded from this review as they did not relate to a Canadian context including 
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data pertaining to language barriers and inability of patients to pay for health care. The most 
common patient-related barriers to providing breast cancer survivorship care reported by primary 
care physicians included the following: patients refused care or were non-compliant with 
recommendations for care (59.6%); and patients requested more cancer surveillance testing than 
recommended by guidelines (53.3%). The most common provider-related barrier was worry over 
missing aspects of survivorship care (56.5%). In addition to this, 51.1% of physicians reported 
that they ordered more tests than recommended by guidelines in order to avoid medical-legal 
consequences of inadequate cancer surveillance. Moreover, 46.4% of physicians reported that 
they had inadequate knowledge and training to care for breast cancer survivors. Other barriers 
included role ambiguity (33.1%) and concern over duplicated care (47.7%). Not surprisingly, the 
more knowledge a physician felt they had on components of breast cancer survivorship care, the 
less likely they were to express uncertainty around their role and surveillance interventions.  
This study had both weaknesses and strengths. Similar to Cheung et al. (2013) and 
Potosky et al. (2011), the findings were based on self-reported data, which may have skewed the 
results based on social desirability bias. Nonetheless, this study was well-laid out, easy to read, 
and captured pertinent data unreported by both Cheung et al. (2009) and Potosky et al. (2011). 
The data was also obtained from a nationally representative sample, therefore increasing the 
generalizability of the results. 
This study is useful in answering the research question as it offers both patient specific 
and provider specific barriers to breast cancer survivorship care. It provides further insight as to 
why primary care physicians order more surveillance tests than recommended by guidelines, 
which disputes this issue being based solely on a knowledge deficit. First, Virgo et al. (2013) 
captured that breast cancer survivors are requesting more surveillance testing than recommended. 
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Second, physicians admitted to ordering more surveillance testing due to concern about missing 
a cancer recurrence. Regardless of these findings, further studies offering new data are required 
to validate this research as to present-day barriers. Also, a qualitative research approach may be 
useful in exploring the findings further, as well as acquiring new insights and providing a richer 
understanding of barriers to breast cancer survivorship care.  
Nekhlyudov, Aziz, Lerro, and Virgo (2013) conducted a quantitative cross-sectional 
study that had two purposes: to compare PCPs’ and oncologists’ awareness regarding late and 
long-term effects associated with chemotherapy for breast cancer; and to see if there was an 
association between this awareness and physician characteristics. The authors utilized data from 
Potosky et al.’s (2011) original study that obtained survey data from a nationally representative 
sample of 2202 primary care physicians and oncologists.  
The results of this study were significant. As mentioned by Potosky et al. (2011), the 
authors found that only 23% of physicians were “very confident” in their knowledge regarding 
late and long-term effects of breast cancer and its treatment. To add to this finding, only 6% of 
physicians reported awareness of all four late or long-term effects of cancer treatment, including 
peripheral neuropathy, cardiac dysfunction, premature menopause, and secondary malignancies, 
as they pertained to doxorubicin, cyclophosphamide, paclitaxel, and/or oxaliplatin. This study 
found a positive association between those reporting less confidence in providing breast cancer 
survivorship care, and those with less knowledge around the late and long-term effects of 
chemotherapy. It was also discovered that physicians’ knowledge increased based on the number 
of breast cancer survivors they saw per year.  
The main strength of this study is that it used a nationally representative sample, 
therefore increasing the generalizability of the results. The main limitation of the study is that it 
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only focussed on late and long-term effects of chemotherapy. The findings would have been 
more comprehensive if additional components of breast cancer survivorship care were assessed, 
such as awareness of psychosocial adverse effects of breast cancer and its treatment. Social 
desirability bias is also a possibility of this study due to the self-reported data. 
Although this study, as well as Cheung et al.’s (2013) and Virgo et al.’s (2013) research, 
utilized the same data originally collected by Potosky et al. (2011), they all gleaned different 
information related to the research question. The results of Nekhlyudov et al.’s (2013) study are 
clear in that few PCPs are confident or knowledgeable in providing breast cancer survivorship 
care as it relates to managing the physical effects of cancer and its treatment. This is a significant 
barrier to breast cancer survivors’ needs being met once transitioned back to their PCP after 
active treatment ends.  
Smith, Murchison, Singh-Carlson, Alexander, and Wai (2015) conducted a well-
organized Canadian quantitative cross-sectional study that sought to compare the perceptions of 
breast cancer survivors and primary care physicians in regards to the capacity of physicians to 
provide breast cancer survivorship care.  It is important to note that the authors utilized 
secondary data from Smith et al. (2011) in the form of PCP surveys, although this was not 
clearly disclosed by the author. Therefore, the survey administration methods can be found in the 
description of Smith et al.’s (2011) study in the later part of this chapter. The data on the 
perceptions of breast cancer survivors were original to this study however. There were 2289 
breast cancer survivors recruited based on eligibility criteria including: they spoke English, had 
completed active treatment, and had no indication of cancer. It was unclear if these participants 
were required to be discharged from their oncologist. Two different surveys were created and 
pilot-tested for the two groups of participants. However, the authors note that the survey 
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instruments were not rigorously validated, which could have improved the validity and reliability 
of the results. Of the participants, there was a 59% response rate for physicians as per Smith et 
al. (2011) and a 47% response rate for breast cancer survivors. The participant sample was 
relatively large, however there was potential for response bias due to the survey methodology 
used. 
Data obtained from the surveys were summarized as frequencies and made transparent to 
readers by use of figures. Results indicated that almost 80% of primary care physicians described 
“good” or “adequate” confidence in their ability to manage all components of breast cancer 
survivorship care. Physicians were most confident in surveillance practices such as screening for 
recurrence, with 77% of respondents reporting a “good” ability in this care component. Whereas, 
physicians expressed least confidence by a “low” ability to deliver family counselling (24%), 
provide sex and body image counselling (26%), and manage lymphedema (24%). Although the 
breast cancer survivor participants were fairly confident in PCPs’ ability to attend to all domains 
of breast cancer survivorship care, they were less confident than PCPs were overall. Breast 
cancer survivors were most confident in PCPs’ ability to screen for recurrence (65%) and least 
confident in PCPs’ competency to attend to the psychosocial aspects of care, such as family 
counselling (41%) or sex and body image counselling (36%). 
Overall, the Smith et al. (2015) study is pertinent to the research question, as the results 
highlight that even though physicians are relatively confident in their ability to provide breast 
cancer survivorship care, they are least confident in psychosocial and physical (i.e. managing 
lymphedema) components of care. Data from breast cancer survivors concurs that PCPs’ ability 
to provide psychosocial aspects of care is suboptimal. PCPs’ high confidence in delivering 
surveillance components of breast cancer survivorship care differs from data obtained by 
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Potosky et al. (2011), which found a majority of respondents were not confident about screening 
for recurrence. However, this difference may be owing to the variation in wording used in the 
surveys, such as “good confidence” versus “very confident.” In sum, the findings of this study in 
combination with the previously discussed studies, suggest PCPs’ may not be highly confident in 
their ability to provide certain components of breast cancer survivorship care.  
Luctkar-Flude, Aiken, McColl, Tranmer, and Langley (2015b) conducted a well designed 
Canadian quantitative cross-sectional study, with objectives to identify which aspects of breast 
cancer survivorship care were being implemented by PCPs, to explore knowledge gaps, and to 
assess the differences between NP and physician care delivery. Prior to conducting this study, the 
authors created evidence-based guidelines for breast cancer survivorship care by conducting a 
systematic review of available guidelines (Luctkar-Flude et al., 2015a). The closed-ended 
questionnaire used in this study was substantiated on this evidence-based guideline. The sample 
of PCPs were chosen based on a comprehensive list of experienced NPs and physicians who 
worked in primary health care settings within the South East Local Health Integration Network 
of Ontario. There were 321 PCPs eligible, and as such were mailed questionnaires. However, 
only 82 PCPs participated, giving this study a 25% response rate. The questionnaires provided 
demographic data, which found that most participants were female and practicing in urban 
settings. The external validity of this study is weak, due to the small sample size, participant 
characteristics, and potential for response bias.  
Results indicated that less than half (46.4%) of the key guideline recommendations for 
breast cancer survivorship care were being implemented and 28.5% of those recommendations 
were unknown to PCPs. Implementation rates were higher for prevention (i.e. contraception, 
osteoporosis, weight management) and surveillance (i.e. mammogram) components of 
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survivorship care, and lower for management of long-term physical and psychosocial effects of 
cancer and its treatment. Those care components with lower implementation rates were also 
areas where knowledge gaps existed.  
Luctkar-Flude et al.’s (2015b) study offers some solid evidence suggesting that there are 
existing deficits related to PCPs’ knowledge in components of breast cancer survivorship care. 
First, comparable to Nekhlyudov et al. (2013), Potosky et al. (2011), and Smith et al. (2015b), 
knowledge and awareness regarding the physical and psychosocial effects of breast cancer and 
its treatment appear to be limited. Second, these findings along with Virgo et al.’s (2013) 
research, highlight that there is a significant proportion of key guideline recommendations for 
breast cancer survivorship care being missed. Each of these findings strongly emphasized 
knowledge or lack thereof, as an underlying barrier to the provision of evidence-based breast 
cancer survivorship care in the primary health care setting.  
Qualitative Studies. Three of the studies retrieved from the literature search are 
classified as qualitative studies. These studies utilized focus groups or one-on-one interviews to 
obtain qualitative data. Key findings obtained from these studies included many of the same 
provider-related barriers described in the descriptive studies, with the addition of new data 
pertaining to system-related barriers and facilitators to breast cancer survivorship care. 
Kantsiper et al. (2009) explored breast cancer survivors’, PCPs’ and oncology specialists’ 
perspectives on their needs, priorities, and approach to breast cancer survivorship care. 
Convenience sampling was used to purposefully select 21 breast cancer survivors, 15 PCPs, and 
16 oncology specialists from the United States. Data were collected from nine focus groups over 
a span of almost two years by the same two facilitators, which allowed the researchers to become 
immersed in the process and collect adequate amounts of data until saturation of themes was 
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obtained. Moreover, having the same two facilitators likely allowed for collection of data to 
occur in a consistent manner across focus groups. The group interviews were semi-structured, 
conducted face-to-face, and recorded verbatim. A qualitative thematic analysis was then used to 
explore the data by the two focus group facilitators and a social scientist with extensive 
experience conducting qualitative research. These methods of data collection and analysis were 
appropriate in meeting the qualitative objectives of the study. However, the accuracy of the 
findings could have been determined by use of member checking, which was not highlighted 
within the article. 
Key findings of the study revealed provider-related barriers and system-related barriers to 
the provision of evidence-based breast cancer survivorship care in the primary health care 
setting. The main theme identified by PCPs was their ambivalence about having responsibility 
for breast cancer survivorship care. The data suggested that this ambivalence was linked with 
role confusion, confidence levels, and knowledge. Many respondents reported that they hardly 
became involved in components of breast cancer survivorship care because they assumed that 
patients were seeing an oncologist for any cancer related issues. Moreover, a majority of PCPs 
felt oncologists should have the responsibility of delivering breast cancer survivorship care, yet if 
required they felt they could assume this role. Pertaining to knowledge in components of breast 
cancer survivorship care, PCPs voiced concerns around cancer surveillance, and missing a cancer 
recurrence in patients. Many voiced fears of medical-legal consequences related to cancer 
follow-up. In addition to this, none of the respondents in the study routinely provided 
psychosocial support to breast cancer survivors, however it was unclear why this was. In regards 
to system-related barriers, themes related to time, survivorship care plans and communication 
with oncologists were presented. Firstly, PCPs reported that they felt challenged by the number 
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of primary care issues that emerge during time-limited appointments with patients, and could not 
possibly add in every component of breast cancer survivorship care. Secondly, some PCPs felt 
they would be more confident providing breast cancer survivorship care if they had written 
survivorship care plans to guide care. Finally, suboptimal communication with cancer specialists 
was regarded as a large barrier to PCPs caring for breast cancer survivors. 
In regards to data obtained from breast cancer survivors, many expressed ambivalences 
about completing active cancer treatment. Being discharged from their cancer care team and 
transitioned back to their PCP left these breast cancer survivors feeling both anxious and 
abandoned. Breast cancer survivors perceived PCPs as not having a central role in breast cancer 
survivorship care and as such felt their needs as cancer survivors were not being met. Breast 
cancer survivors felt a written document such as a discharge letter or a survivorship care plan and 
ongoing communication between their PCP and oncologist would facilitate better coordination of 
their care after active cancer treatment ends.  
This study is useful in answering the research question because it presented both provider 
and system-related barriers to the provision of evidence-based breast cancer survivorship care, 
including role ambivalence, workload issues, and perceived suboptimal oncologist support in 
place for PCPs. Data from breast cancer survivors confirmed many of the same barriers reported 
by PCPs. The qualitative method used to obtain data allowed for new themes to emerge that had 
not appeared in the aforementioned descriptive studies, such as system-related barriers. At the 
same time, this research reinforces barriers found in the studies already discussed including: 
preference for an oncologist-led survivorship care model; lack of confidence in providing care to 




O’Brien, Grunfeld, Sussman, Porter, and Mobilio’s (2015) study was systematic and 
transparent in the entire research process. The authors’ first objective was to gain an 
understanding of the experiences of family physicians in their role of providing breast cancer 
survivorship care in Canada. The second objective was to gain an awareness about the 
experience physicians have with cancer survivorship care plans and oncologist discharge letters. 
The authors chose a descriptive qualitative design in order to focus on the human experience and 
allow themes to emerge. The participants consisted of family physicians of women with breast 
cancer who had participated in a previous randomized controlled trial (RCT). An invitation to 
participate in the study was mailed to 123 purposefully selected family physicians. Although 
50% of physicians did not respond and 11% declined, the authors felt they had adequate data 
saturation after interviewing 15% (18) of the eligible physicians. The sample size was diverse 
based on the participants’ demographic characteristics. Interviews were semi-structured and 
conducted by one experienced team member, which kept the data collection process consistent. 
The interviews, which were conducted over the telephone and one-on-one, minimized the 
possibility of social desirability bias.   
Results of this study were thought-provoking. In regards to a survivorship care plan, 
which consists of a record of care (i.e. summary of cancer and its treatment), reminder checklist 
for care (i.e. dates to recall patients for care) and breast cancer survivorship guidelines (i.e. 
prevention, surveillance, coordination, and intervention), most respondents voiced that a one-
page record of care was the only useful aspect of these care plans. Most physicians found 
reminder checklists useless, as they used online systems with patients’ Electronic Medical 
Records (EMR) to recall the patient. With regards to oncologist discharge letters, respondents 
had variable views regarding their value. More respondents were concerned about timely 
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ongoing communication with oncologists, rather than inadequate discharge letters. Equally 
important to these findings, physicians felt they were well-suited to provide breast cancer 
survivorship care, but indicated they were not comfortable taking over care until three to five 
years after diagnosis. They also perceived breast cancer survivorship care as limited to 
conducting CBEs and ordering mammograms, which in actuality is only attending to the 
surveillance components of care required (Luctkar-Flude et al., 2015a).  
In sum, this study validates knowledge gaps related to components of breast cancer 
survivorship care as found in many of the previous studies (Kantsiper et al., 2009; Luctkar-Flude 
et al., 2015b; Nekhlyudov et al., 2013), and supports the concept that PCPs may be ambivalent in 
taking over care of breast cancer survivors after active cancer treatment is complete (Kantsiper et 
al., 2009; Virgo et al., 2013). Although most physicians in this study felt they were well-suited to 
provide breast cancer survivorship care, this finding may be due to them perceiving breast cancer 
survivorship care as only ordering annual mammograms and conducting CBEs. If care was 
delivered based on breast cancer survivorship guidelines it would not be as straightforward and 
as such, one may speculate that these PCPs would not feel as well-suited to care for breast cancer 
survivors.  
Luctkar-Flude et al. (2018) conducted a transparent and clearly reported qualitative 
descriptive study that sought to understand barriers and facilitators related to PCPs implementing 
evidence-based breast cancer survivorship care in Canada. The authors used a combination of 
purposive and snowball sampling to recruit 10 physicians and 9 NPs from an area in Ontario that 
serves more than 500,000 individuals. A significant limitation of the study was the lack of 
diversity between the participants with 15 of the 19 PCPs being women. Data was collected in 
semi-structured, pilot-tested one-on-one interview sessions that were conducted by the same 
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researcher and recorded and transcribed verbatim. Data saturation was determined in this study 
due to the recurrence in themes, which improves the credibility of the results. Prior to coming to 
their conclusions, the authors maintained the rigour of their study by using peer review, member 
checking, and triangulation strategies.  
Results were displayed in an easy to read table and included six themes related to barriers 
and facilitators of delivering breast cancer survivorship care including: inadequate educational 
preparation; provider anxieties; primary care burden; tools and technology; empowering 
survivors; and optimizing nursing roles. Respondents reported that they received no formal 
education on breast cancer survivorship care and therefore, they experienced challenges related 
to knowledge gaps and keeping up-to-date with evidence-based guidelines. PCPs had fears of 
medical-legal consequences related to patients falling through the cracks and as such, having 
cancer recurrence go unnoticed. Individuals with more confidence in providing care to breast 
cancer survivors were those with prior experience. Preferences in cancer survivorship care 
models were divided, with some PCPs feeling it was not their responsibility, and others voicing 
they were ideal candidates to assume such roles. In regards to system-related barriers, PCPs felt 
that their primary care workload would not accommodate the higher acuity care required for 
breast cancer survivors. Moreover, PCPs believed that breast cancer survivorship care would 
cause increased burden on administrative staff related to EMRs and recall procedures. Lastly, 
concern was voiced over inadequate access to oncologists for support.  
This study is a new source of evidence that addresses the research question of this review. 
The provider-related barriers and system-related barriers found in this study are consistent with 
several other sources of research (Kantsiper et al., 2009; O’Brien et al., 2015; Virgo et al., 2013), 
improving the reliability and validity of the results. It is important to note that these qualitative 
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findings not only represent barriers to the provision of evidence-based breast cancer survivorship 
care, but also suggest facilitators to care.  
Mixed-Methods Studies. The remaining two articles found for this integrative review 
are classified as mixed-methods studies. Data obtained from these studies included provider and 
system-related barriers in support of the aforementioned findings.   
Smith et al. (2011) conducted a convergent parallel mixed-methods Canadian study for 
the purpose of assessing the confidence of primary care physicians in their ability to provide 
breast cancer survivorship care, and to explore strategies that physicians felt could improve their 
ability to provide survivorship care. A questionnaire, with both closed and open-ended questions 
was mailed to 1000 randomly selected physicians who cared for at least one breast cancer 
survivor who was discharged from BC Cancer between June 2007 and August 2008. Of those 
questionnaires 587 surveys were eligible for review, providing an adequate response rate of 59%.  
The quantitative results of this study were meaningful. As previously mentioned in the 
findings of Smith et al. (2015), the questionnaires identified that physicians were most confident 
in conducting screening for recurrence, and least confident in counselling women on sex and 
body image, providing family counselling, and managing lymphedema. High confidence levels 
in screening for recurrence was significantly associated with increased numbers of breast cancer 
survivors seen by the physician, whereas there were no associations found for those care 
components PCPs are least confident providing (Smith et al., 2011). In addition to confidence 
levels, the study also explored possible system-related barriers to care. A high number of 
respondents (80%) conveyed that they “always” received a discharge letter from oncologists and 
92% found them useful. Some PCPs (43%) preferred these discharge letters to be point-form, 
whereas others (38%) preferred both point form and detailed data. Even though most physicians 
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preferred point form discharge letters, interestingly they perceived a large range of information 
“very useful” in the discharge letters including: diagnosis and treatment summary (97%), 
recommended follow-up (96%), recommended adjuvant hormone therapy (92%), summary of 
active issues (85%), reminder checklist for follow-up (85%), summary of potential toxicities 
(84%), and prognosis (84%). Of least perceived use were evidence-based guidelines on breast 
cancer survivorship care (61%), and lists of community resources for breast cancer survivors 
(56%).  
In regards to the qualitative data, the most common themes found were summarized in 
the article. The majority of respondents reported that they would like more information 
pertaining to hormonal therapy and surveillance components of breast cancer survivorship care. 
Physicians also voiced that they felt the transition of care from oncologists to PCPs could be 
improved with “complete information.” One may hypothesize they want “complete information” 
on a discharge letter, including the most useful information previously discussed. 
The study did have its limitations. The lack of detail concerning the participants’ 
characteristics weakens the external validity of the study, as the authors were unable to confirm 
the generalizability of the results. Other limitations of the study included: the authors did not 
state how the open-ended qualitative data was analyzed; the results of this portion of the 
questionnaire were only briefly discussed; and a more comprehensive review of the qualitative 
data was not published in a separate article. Nonetheless, with the use of random selection and an 
adequate response rate, the quantitative data of this mixed-methods study provides reliable 
insight of primary care physicians’ perceived strengths and weaknesses related to the provision 
of evidence-based breast cancer survivorship care. 
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The results of this study inform the research question, and further support the other 
research used for this integrative review. First, the more breast cancer survivors a PCP followed 
in practice, the more confident they were in providing surveillance components of care 
(Nekhlyudov et al., 2013; Smith et al., 2011). Second, PCPs wanted a wide range of “complete” 
discharge information from the oncologist (Kantsiper et al., 2009), whether that be provided on a 
discharge letter or a survivorship care plan. Finally, physicians wanted more information on 
surveillance components of breast cancer survivorship care after active cancer treatment ends. 
Dawes et al.’s (2015) explanatory sequential mixed methods study explored PCPs’ 
knowledge, attitudes, and confidence in providing breast cancer survivorship care in the United 
States. Out of the 115 PCPs eligible to participate in the study, including physicians, NPs, and 
physician assistants, 59 participated (51%). The small sample size, along with the small 
geographical region where recruitment took place in Los Angeles, were the main limitations of 
this study as they decreased the generalizability of the quantitative results. The authors utilized 
the National Cancer Institute’s validated Survey of Physician Attitudes Regarding the Care of 
Cancer Survivors (SPARCCS) tool created by Potosky et al. (2011) to gather quantitative data 
related to the purpose of the study. The response rate was adequate at 51%. All participants who 
returned their survey were eligible to attend three sequential focus group sessions that included 
structured and open-ended questions. Out of the 59 eligible to attend, 12 to 25 PCPs were present 
at each session which is an adequate sample for the purpose of obtaining qualitative data.  
The findings of this study were clearly reported. The authors found that PCPs were 
lacking confidence in their ability to perform breast cancer survivorship care as evidenced by 
only 25% of respondents being “very confident” in their ability to manage psychosocial effects 
of cancer and its treatment, 14% managing physical effects and 22% detecting recurrence. In 
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respect to knowledge, over half of the PCPs (63%) felt they had the skills to monitor for 
recurrence, however only 10% of respondents ordered surveillance testing that complied with 
breast cancer survivorship guidelines. In addition, less than half (39%) of the PCPs felt they had 
the necessary skills to provide other aspects of breast cancer survivorship care. Data on PCPs’ 
preferred care models of breast cancer survivorship care found that only 10% of participants felt 
PCPs should be responsible for breast cancer survivorship care, as most preferred an oncologist-
led model of care (40%), a specialized clinic model (28%), or a shared-care model (22%). 
Themes related to barriers for transition included timing, unfamiliarity with ongoing hormonal 
therapy regimens, and role ambiguity. Facilitators included additional training in cancer specific 
care, and survivorship care plans.  
This research reports similar themes found in the other studies utilized in this integrative 
review and as such, further supports the validity of those findings as a comprehensive body of 
knowledge. Moreover, this study utilized the SPARCCS instrument, which was also used to 
obtain primary data by Potosky et al. (2011). The repeated use of the SPARCCS further 
contributes to the instrument’s validation, because it produced the same results as Potosky et al. 
(2011) including PCPs’ having low confidence levels and knowledge deficits related to breast 
cancer survivorship care, as well as PCPs’ being least in favor of a PCP-led care model. In 
addition to supporting evidence found in other studies, new barriers were expressed including 
concerns around the timing of transitioning breast cancer survivors back to their PCPs, as well as 
knowledge deficits related to hormonal therapy. The findings of this research are valuable in 





Summary of Findings 
 In summary, the research has indicated significant provider-related and system-related 
barriers to the delivery of evidence-based breast cancer survivorship care in the primary health 
care setting. PCPs’ ambivalence over assuming care of breast cancer survivors is reflected in 
their preference for an oncologist-led or shared-care model (Dawes et al., 2015; Cheung et al., 
2013; Kantsiper et al., 2009; Potosky et al., 2011), as well as their desire for transition of care to 
occur much later than what is expected in a PCP-led model of breast cancer survivorship care 
(Dawes et al., 2015; O’Brien et al., 2015). Breast cancer survivorship guidelines such as those 
devised by Luctkar-Flude et al. (2015a) and Sisler et al. (2016) have attempted to increase PCPs’ 
confidence in caring for this patient population. However, adherence to guidelines and associated 
recommendations remains low (Dawes et al., 2015; Luctkar-Flude et al., 2015b; O’Brien et al., 
2015; Potosky et al., 2011; Virgo et al., 2013), as does knowledge in components of breast 
cancer survivorship care (Dawes et al., 2015; Kantsiper et al., 2009; Luctkar-Flude et al., 2015b; 
Luctkar-Flude et al., 2018; Nekhlyudov et al., 2013; O’Brien et al., 2015), and confidence in 
caring for breast cancer survivors (Cheung et al., 2013; Dawes et al., 2015; Luctkar-Flude et al., 
2018; Nekhlyudov et al., 2013; Potosky et al., 2011). The evidence retrieved further indicates 
system-related barriers including: increased burden in primary health care settings (Kantsiper et 
al., 2009; Luctkar-Flude et al., 2018); and inconsistent communication, support, and transition 
from oncologists (Kantsiper et al., 2009; Luctkar-Flude et al., 2018; O’Brien et al., 2015; Smith 
et al., 2011). In sum, provider and system-related barriers confound the provision of evidence-
based breast cancer survivorship care in the primary health care setting. These findings will be 
further examined as they relate to solutions to mitigate these barriers in the following discussion 




Discussion and Recommendations 
The research evidence presented in the findings chapter has provided the basis for 
numerous insights into my research question. This chapter will further address those research 
findings by first discussing provider-related barriers including PCPs’ knowledge and attitudes. 
Secondly, system-related barriers will be discussed including PCPs’ workload and support 
systems in place. Finally, as this is the main utility of the research findings, strategies to 
overcome the identified barriers will be explored throughout this chapter in order to pave the 
way for new research and progress in breast cancer survivorship care. 
Provider-Related Barriers 
Provider-related barriers are both personal to the provider and to a large extent 
modifiable. Identifying and overcoming provider-related barriers are the first steps in improving 
the delivery of breast cancer survivorship care in the primary health care setting. Addressing 
system-related barriers to breast cancer survivorship care without first identifying personal 
attitudes and abilities of PCPs to provide this form of specialized care would most certainly be 
challenging. The issue would be that even if every system-related barrier was overcome in a 
practice setting, the care of breast cancer survivors would remain suboptimal if the PCP 
continued to be challenged by personal barriers. Therefore, the initial discussion will focus on 
provider-related barriers gleaned from the research findings including PCP knowledge deficits 
and attitudes regarding breast cancer survivorship care.  
Knowledge. Knowledge deficits among PCPs are a key barrier to breast cancer 
survivorship care that necessitates improvement. It is important to note that four of the eleven 
studies utilized in this integrative review found that over 50% of PCPs reported they had the 
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overall knowledge to provide breast cancer survivorship care including Cheung et al. (2013), 
Potosky et al. (2011), Smith et al. (2015), and Virgo et al. (2013). However, Potosky et al. (2011) 
and Virgo et al. (2013) found evidence suggesting otherwise based on the significant number of 
PCPs ordering inappropriate surveillance testing as per the evidence-based guidelines for breast 
cancer survivorship care. Furthermore, Nekhlyudov et al. (2013) found that the less confident a 
PCP is in providing breast cancer survivorship care, the less knowledge they have on this type of 
care. Although a majority of Cheung et al.’s (2013) and Potosky et al.’s (2011) participants felt 
they had the skills to provide breast cancer survivorship care, only a small number of those same 
participants expressed confidence in doing so. In other words, even if one perceives an ability to 
provide components of breast cancer survivorship care it does not mean evidence-based care is 
being provided or that the underlying knowledge to provide that care exists. Nevertheless, 
without adequate knowledge concerning the impacts of breast cancer and its treatment, as well as 
awareness of evidence-based guidelines, numerous components of breast cancer survivorship 
care are being missed. The research evidence indicates that this knowledge deficit is linked to 
educational preparation, self awareness, and the overall experience PCPs have with breast cancer 
survivors in practice, which will be further discussed in the following paragraphs.  
Education. Firstly, the educational programs for PCPs may not support foundational 
knowledge required to care for breast cancer survivors. The studies done by Kantsiper et al. 
(2009), Luctkar-Flude et al. (2018), and Virgo et al. (2013) highlight that many PCPs have no 
formal education on the effects of breast cancer and its treatment, thus making it difficult to 
provide breast cancer survivorship care in practice. These studies recognize that most entry-level 
NPs and physicians do not have an adequate knowledge base to support evidence-based care of 
breast cancer survivors. Therefore, integrating breast cancer survivorship education in the 
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program curricula of the institutions training NPs and physicians could increase PCPs’ 
knowledge and confidence in caring for breast cancer survivors in practice.  
In conjunction to a change in program curricula, due to the rapidly evolving nature of 
breast cancer care it is also imperative for PCPs to have continuing education opportunities. The 
focus of this education should be on components of breast cancer survivorship care that PCPs 
appear to be least confident in providing such as the psychosocial and physical consequences of 
breast cancer and its treatment (Dawes et al., 2015; Kantsiper et al., 2009; Luctkar-Flude et al., 
2015b; Luctkar-Flude et al., 2018; Potosky et al., 2011; Smith et al., 2015), and those 
components in which PCPs are lacking knowledge, such as evidence-based surveillance practices 
(Dawes et al., 2015; Potosky et al., 2011). The literature indicates that offering a wide range of 
education formats including webinars, lunch-and-learns, and continuing medical education 
events and workshops would best meet the diverse learning needs and availability of PCPs 
(Kantsiper et al., 2009; Luctkar-Flude et al., 2018).  
Awareness. It is important to note that lacking knowledge in certain subject matter is 
only modifiable if the PCP is aware of that deficit. Luctkar-Flude et al. (2015) and O’Brien et al. 
(2015) emphasized that unbeknownst to many of the PCPs involved in their studies, numerous 
components of breast cancer survivorship care were being missed. Further insight into this issue 
is provided by Dawes et al. (2015) and Potosky et al. (2011), who found PCPs were significantly 
deviating from the evidence-based guideline recommendations for surveillance practices, which 
could lead to more harms than benefits for the breast cancer survivor. The literature suggests that 
this lack of awareness is in part due to PCPs not being cognizant of the evidence-based 
guidelines available to direct practice (Dawes et al., 2015; Luctkar-Flude et al., 2018; O’Brien et 
al., 2015), such as national guidelines (Luctkar-Flude et al., 2015a; Sisler et al., 2016) or 
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provincial guidelines (Alberta Health Services, 2015; BC Guidelines, 2013). These studies 
emphasize the importance of knowledge translation, because access to and uptake of evidence-
based guidelines is vital to provide optimal patient care.  
Knowledge translation is defined by the Canadian Institutes of Health Research (2016) as 
“…a dynamic and iterative process that includes the synthesis, dissemination, exchange and 
ethically sound application of knowledge to improve health, provide more effective health 
services and products, and strengthen the health care system” (para. 4). There are numerous 
knowledge translation strategies to increase the use of evidence-based guidelines in breast cancer 
survivorship care. Firstly, it is important to engage PCPs by allowing them to identify types of 
guidelines on breast cancer survivorship care they would find useful in practice. As noted by Ali, 
Roffe, and Crome (2012), stakeholders need to be involved at the beginning of research planning 
so that the study can better meet the needs of the people who are going to be affected by its 
outcome and thus, increase the uptake of research findings in practice including evidence-based 
guidelines. Secondly, PCPs need to be involved in reviewing the research data and identifying 
barriers to implementing the recommendations highlighted in the findings. For example, 
evidence-based guidelines may need to be refined by way of contextualization before 
dissemination in order to overcome barriers of research uptake by stakeholders, therefore 
increasing the likelihood of knowledge translation (Graham et al., 2006; Mold & Peterson, 
2005). Thirdly, preferred methods of research dissemination need to be identified by 
stakeholders in order to improve access and utilization of the research findings in practice 
(Straus, Tetroe, & Graham, 2009). If knowledge translation strategies are employed to 
disseminate novel research on breast cancer survivorship care including evidence-based 
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guidelines, there is a better probability of PCPs accessing these resources and in turn building 
their awareness, knowledge, and confidence in caring for breast cancer survivors. 
Experience. Beyond access to further education and evidence-based guidelines, PCPs 
require experience with breast cancer survivors in order to broaden their abilities to manage these 
patients. Not surprisingly, the more exposure to breast cancer survivors a PCP has, the greater 
their confidence in caring for this population (Cheung et al., 2013; Luctkar-Flude et al., 2018; 
Nekhlyudov et al., 2013; Smith et al., 2011; Virgo et al., 2013). Therefore, a key barrier to the 
provision of evidence-based breast cancer survivorship care in the primary health care setting is 
PCPs not having adequate numbers of breast cancer survivors in their practice, and in turn, not 
having the opportunity to develop expertise in providing this form of care.  
A common theme throughout the research evidence is that the majority of PCPs are least 
confident in managing the psychosocial and physical effects of cancer and its treatment and most 
confident with the prevention and surveillance components (Dawes et al., 2015; Kantsiper et al., 
2009; Luctkar-Flude et al., 2015b; Luctkar-Flude et al., 2018; Potosky et al., 2011; Smith et al., 
2015). A correlation found in the literature is that the more experience a PCP has with providing 
certain components of breast cancer survivorship care, the more adept they are at providing this 
care (Luctkar-Flude et al., 2015b). Therefore, one may hypothesize that PCPs have more 
confidence in prevention and surveillance practices as these components of breast cancer 
survivorship care have a large role in primary health care settings in general, which gives PCPs 
more experience in these matters. Whereas, many of the physical and psychosocial effects of 
breast cancer survivors are more specific to the cancer and treatment itself, necessitating a larger 
breadth of knowledge and expertise.  
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PCPs involved in the care of breast cancer survivors require a high degree of expertise in 
caring for this population, similar to PCPs involved in caring for those during active breast 
cancer treatment. However, the standards of training and experience are different for those PCPs 
caring for breast cancer patients versus breast cancer survivors. PCPs working with breast cancer 
survivors are not required to have any additional training in cancer care, whereas additional 
training to become a General Practitioner in Oncology (GPO) or, in BC, a Nurse Practitioner in 
Oncology (NPO) is a requirement for those PCPs caring for patients in the active treatment phase 
of the cancer care trajectory (The Canadian Association of General Practitioners in Oncology 
[CAGPO], 2019). Having an understanding of breast cancer and its treatment is foundational 
knowledge required to care for those who are receiving active cancer treatment, as well as for 
cancer survivors.  
Perhaps the same standards of training and experience should be expected of PCPs caring 
for women with breast cancer in both treatment and survivorship. A system in which breast 
cancer survivors are followed by a subset of PCPs with specialized and advanced education in 
cancer care, could better facilitate evidence-based breast cancer survivorship care in the primary 
health care setting. To clarify, even though these PCPs would not be involved in managing active 
cancer treatments, they still require an understanding of the treatment these women are receiving 
as it is highly linked to the chronic, late, and/or permanent effects that need to be monitored in 
the survivorship phase of the cancer care trajectory. In addition to this foundational knowledge, 
these PCPs would need additional training focussed on cancer survivorship care related to post 
active cancer treatment prevention, surveillance, intervention, and coordination. To be clear, the 
role of these PCPs with expertise in cancer care would not be to function in the same role as a 
GPO and/or NPO, whose purpose is to provide cancer treatment such as systemic therapy (i.e. 
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chemotherapy) in collaboration with oncologists in tertiary cancer centres. Rather, their primary 
purpose would be to provide care to breast cancer survivors within a primary health care context. 
Thus, these diverse providers would have the same foundational knowledge in cancer care, but 
different roles and settings in which this knowledge is applied.   
Nurse practitioners. In recommending the creation of a subset of PCPs with specialized 
and advanced education in cancer care, it is also important to determine if one type of PCP is 
better suited for the role than another. Although NPs and physicians have differing educational 
backgrounds, the literature suggests that they provide comparable care as evidenced by 
equivalent health outcomes in breast cancer survivors (Cooper et al., 2010; Kenison, Silverman, 
Sustin, & Thompson, 2015), and similar implementation rates of breast cancer survivorship 
guidelines (Luctkar-Flude et al., 2015b). However, some evidence also indicates that breast 
cancer survivors experience increased satisfaction with care provided by a NP versus a physician 
(Cureton, Pritham, Royce, & Zahns, 2009; Mayer et al., 2012).  
Even though NPs and physicians have many similarities in scope of practice and role in 
primary health care, ideological differences in their care approach may position NPs to better 
meet the unique needs of patients in the survivorship phase of the cancer care trajectory. For 
example, NPs have a nursing background strongly rooted in the holistic care approach, which 
promotes a form of care that is essential to meet the multidimensional needs of breast cancer 
survivors (IOM, 2006; Ng, Ong, Jegadeesan, Deng, & Yap, 2017). Furthermore, nursing models 
of practice have a strong focus in health promotion and disease prevention, whereas medical 
models of practice often have a narrower focus on the treatment of disease (DiCicco-Bloom & 
Cunningham, 2015). A large component of breast cancer survivorship care is the use of health 
promotion and disease prevention to help women achieve health as it relates to overall physical, 
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emotional, mental, and social wellbeing, rather than achieve health as solely the absence of 
disease. In other words, care that is provided based on the nursing philosophy is care that 
facilitates breast cancer survivorship care. The unique attributes of a NP strongly suggest that 
they are well suited to provide optimal breast cancer survivorship care, and without question 
should have a central role in caring for this high need population (Cureton et al., 2009; Mayer et 
al., 2012). 
In addition to NPs’ grounding within the philosophical tenets of nursing, serving 
vulnerable patients, such as those involved in the cancer care trajectory, is in line with many of 
the current roles undertaken by NPs across Canada (Canadian Federation of Nurses Unions 
[CFNU], 2018). NPs are often utilized to fill a void in Canada’s primary health care system and 
to work with underserved populations in the most need (CFNU, 2018). Since the evidence found 
in this integrative review identified that there is a gap in breast cancer survivorship care, perhaps 
the growing number of NPs in Canada (Canadian Nurses Association, 2019) could help close 
this gap in care.  
The concept of a NP-led model of cancer survivorship within a primary health care 
context is not new. However, this NP role is currently underutilized in Canada based on available 
data. The first NP-led model of cancer survivorship care in Canada was developed in Toronto in 
2012, specifically for survivors of colorectal cancer (North York General, 2017; Ruffell, n.d.). 
This survivorship program is independently run by two NPs with specialized education in cancer 
care. In addition to the Toronto program, in 2013 BC Cancer created a Survivorship Nurse 
Practitioner Program with the purpose of utilizing NPs with advanced education in cancer care to 
provide full-spectrum primary health care to cancer survivors who have completed active cancer 
treatment and do not have a regular PCP to transition back to (BC Cancer, 2019; Provincial 
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Health Services Authority [PHSA], 2013). Based on available data there are only three NPs 
currently involved in this BC Cancer program, all located in the Lower Mainland of BC (BC 
Cancer, 2019).  
With only a small number of NPs involved in survivorship care in Canada, this 
specialized role is not being sufficiently utilized as a strategy to improve the cancer survivorship 
experience for breast cancer survivors. At the same time, there is little available data on how 
effective this NP role is in closing the gap in cancer survivorship care in Canada. The only study 
available on this concept was done in the United States by McCabe et al. (2016) who found NP-
led cancer survivorship clinics as a beneficial strategy to deliver optimal care to cancer survivors 
in accordance to the IOM’s (2006) standards of care. Future research efforts should be taken to 
further identify the effectiveness of NPs in a cancer survivorship role within a primary health 
care context and how best they can be incorporated into Canada’s health care system.  
There are barriers to establishing a role for NPs in cancer survivorship care in Canada 
and therefore, having this recommendation come to fruition. Firstly, approval and funding of 
such a role would have to be made by key stake-holders, such as regional and provincial health 
authorities. Approval would require strong evidence of a recognized need, buy-in of key stake-
holders, and the appropriate resources to implement the role. Secondly, cancer care training with 
a focus on cancer survivorship would have to be created for NPs to take in Canada, as the 
expectation would be that they become cancer survivorship experts. Thirdly, issues recruiting 
NPs with an interest in obtaining specialized education in cancer care to every community in 
need of this resource would likely also be a problem, as many NP positions in rural and remote 
communities remain unfilled for extended periods of time (Auditor General of British Columbia, 
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2018). Lastly, many patients with a strong rapport with their PCPs may not want to be 
transitioned to a different PCP after their active cancer treatment ends.  
Due to these potential barriers, as well as the growing population of breast cancer 
survivors, it would be unrealistic to expect every one of these women to be followed by a NP 
with expertise in cancer survivorship care. At the same time, any number of NPs with this 
expertise is likely to contribute to improving care of breast cancer survivors overall. The role has 
potential to have far reaching effects on all primary health care settings through its contribution 
to interdisciplinary teams. The fact of the matter is, a two-pronged approach to facilitate 
evidence-based breast cancer survivorship is required, with both the utilization of NPs with 
specialized and advanced education in cancer care, and generalist PCPs who would continue 
their essential role in caring for breast cancer survivors. Consequently, all entry-level PCPs 
would still require the basic education and awareness to care for this population, as well as 
hopefully buy-in to a PCP-led model of breast cancer survivorship care.  
Attitudes. The attitudes of PCPs, as they relate to having the responsibility to care for 
breast cancer survivors, was identified in the research findings as a significant barrier of breast 
cancer survivorship care that currently requires a change. In order for PCPs to meet the 
expectation that they take over care of breast cancer survivors once cancer treatment is complete, 
they must buy-in to a PCP-led model of breast cancer survivorship care and have more clarity 
over their significant role in caring for breast cancer survivors. The following paragraphs will 
discuss the research findings as they relate to PCPs’ preferences in models of breast cancer 
survivorship care, as well as PCP role ambiguity and how these factors pose a significant 
challenge to the care of breast cancer survivors in the primary health care setting. 
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Preference in care model. In order to optimize PCPs’ attitudes regarding breast cancer 
survivorship care it will be imperative to change their preference in care model. Dawes et al. 
(2015), Cheung et al. (2013), Kantsiper et al. (2009), and Potosky et al. (2011) found that most 
PCPs’ preferred an oncologist-led care model, shared-care model, or specialized clinic model of 
breast cancer survivorship care over a PCP-led care model. The research evidence highlighted 
numerous reasons for PCPs’ ambivalence in assuming a primary role in the care of breast cancer 
survivors. Firstly, this preference appeared to be strongly tied to PCPs experience with breast 
cancer survivors, and thus confidence in their ability to care for this population. Not surprisingly, 
Cheung et al. (2013), Luctkar-Flude et al. (2018), and Nekhlyudov et al. (2013) found that PCPs 
with greater experience caring for breast cancer survivors were significantly more likely to 
support a PCP-led care model. Secondly, studies done by Kantsiper et al. (2009), Luctkar-Flude 
(2018), and Virgo et al. (2013) emphasized PCPs’ concern regarding the medicolegal 
repercussions of having primary onus of monitoring for and perhaps missing a cancer recurrence. 
This fear is not unreasonable given that the process of diagnosis is recognized by the World 
Health Organization as an area of clinical practice that has a high risk for error (Singh, Schiff, 
Graber, Onakpoya, & Thompson, 2017). These key findings further support a system in which 
breast cancer survivors are seen by a subset of PCPs with more expertise in cancer care. 
However, additional education, improved uptake of evidence-based guidelines, and more 
confidence has the potential to enhance any PCPs’ desire to care for breast cancer survivors. 
Lastly, and perhaps most importantly, many PCPs expressed significant system-related barriers 
that do not support a PCP-led model of breast cancer survivorship care, which will be discussed 
later in this chapter.  
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Beyond acknowledgment of provider and system-related barriers that influence some 
PCPs’ aversion to a PCP-led model for breast cancer survivorship care, it is important to 
recognize reasons why this model of care is desirable in order to generate more buy-in from 
PCPs. To start with, it may better meet the needs of breast cancer survivors in comparison to 
other care models. Cancer treatment is best delivered by an oncologist in a specialized tertiary 
care setting, because the focus is on disease control and/or eradication. However, the emphasis of 
breast cancer survivorship should not be on disease, but rather on health and the quality of one’s 
life. Therefore, breast cancer survivorship care may be best delivered by a PCP in a primary 
health care setting, because both the provider and setting encourage this important shift in focus 
beyond disease. A PCP-led care model allows breast cancer patients to become breast cancer 
survivors. In addition to this, these women often have built a good rapport with their PCP over 
the many years of seeing them. As a result, the PCP has likely developed knowledge of the 
numerous contexts inherent to the breast cancer survivor that can support not only evidence-
based care, but also holistic, patient-centred care. In this regard, continuity of care is not lost 
during the transition of these women back to their PCPs, but perhaps found again after being 
discharged from a cancer care system in which patients are likely seeing a myriad of different 
health care providers (Canadian Partnership Against Cancer, 2018). A PCP-led care model 
allows breast cancer survivors to have a consistent health care provider navigating their care and 
attending to their needs, which can lead to improved health outcomes and decreased role 
ambiguity. 
Role ambiguity. Role ambiguity as described by Dawes et al. (2015), Kantsiper et al. 
(2009), and Virgo et al. (2013) is another key barrier to the provision of evidence-based breast 
cancer survivorship care. As mentioned, there are numerous components of breast cancer 
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survivorship that are involved in the care of a cancer survivor including prevention, surveillance, 
intervention, and coordination services. The literature found that PCPs were not attending to 
certain components of breast cancer survivorship care because they assumed aspects of care were 
being dealt with by other providers such as oncologists (Kantsiper et al., 2009). This key finding 
is concerning for numerous reasons including one’s cancer recurrence going unnoticed due to 
nobody being involved in surveillance components of care. This issue of role ambiguity is in part 
connected to suboptimal communication between PCPs and oncologists during the transition of 
breast cancer survivors back to the primary health care setting once active cancer treatment ends, 
and will be discussed in the following section of this chapter.   
System-Related Barriers 
Acknowledging system-related barriers further describes current issues opposing the 
provision of evidence-based breast cancer survivorship care within a primary health care context. 
Furthermore, looking at what is not working in the current systems in place for the care of breast 
cancer survivors provides a more comprehensive representation of the change that needs to 
occur. Thus, the remainder of this chapter will discuss system-related barriers discovered in the 
research evidence including workload demands and perceived suboptimal oncologist support, as 
well as strategies to overcome these barriers.  
Workload. The demanding nature of PCPs’ workload in a primary health care context 
was a common barrier discussed within the research evidence. Not surprisingly, workload as a 
barrier did not present itself in the deductive approaches seen in the quantitative studies. Rather 
this data became apparent within the qualitative studies of Kantsiper et al. (2009) and Luctkar-
Flude et al. (2018), whose participants voiced concern over limitations in time to provide breast 
cancer survivorship care. PCPs already feel challenged by patients with numerous chronic health 
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issues (Kantsiper et al., 2009), let alone meeting the multidimensional needs of breast cancer 
survivors within a time-limited appointment. It is apparent that current systems and/or processes 
in place may not be appropriate, especially given the increasing number of breast cancer 
survivors in Canada.  
Due to the growing number of breast cancer survivors and the current role of PCPs in 
providing care to this population, it is advantageous for clinics to adopt a team-based approach to 
primary health care to decrease workload demands. The literature suggests that a team-based 
approach could facilitate evidence-based breast cancer survivorship care in the primary health 
care setting (Alberta Health Services, 2015; Luctkar-Flude et al., 2015a; Luctkar-Flude et al., 
2018), especially for PCPs who do not have specialized and advanced education in cancer care. 
Team-based care is defined as:  
“…the provision of health services to individuals, families, and/or their communities by 
at least two health providers who work collaboratively with patients and their 
caregivers—to the extent preferred by each patient—to accomplish shared goals within 
and across settings to achieve coordinated, high-quality care” (Mitchell et al., 2012, p. 5). 
A team-based approach to care is much more likely to facilitate evidence-based breast cancer 
survivorship care rather than a setting in which PCPs are working in silos. This is especially true 
since the research evidence highlighted that a majority of PCPs prefer not to have sole 
responsibility of caring for breast cancer survivors (Dawes et al., 2015; Kantsiper et al., 2009; 
Luctkar-Flude et al., 2018; Potosky et al., 2011). 
A team-based approach to care alleviates provider and system-related barriers including 
knowledge deficits and workload demands, because it allows an interdisciplinary team of health 
care providers with diverse backgrounds and areas of expertise to tend to the needs of breast 
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cancer survivors as a team. For example, Kantsiper et al. (2009) found that PCPs did not 
routinely provide psychosocial support to breast cancer survivors they were caring for. Although 
the study did not explicitly identify why this was, it is reasonable to assume that time limitations 
and knowledge deficits combined could create a barrier to managing the psychosocial 
consequences of breast cancer including distress, anxiety, and depression. As recommended by 
guidelines for breast cancer survivorship care (Alberta Health Services, 2015; BC Guidelines, 
2013; Luctkar-Flude et al., 2015a; Sisler et al., 2016), mental health clinicians who specialize in 
counselling services could be utilized to better meet the psychosocial needs of breast cancer 
survivors. Physiotherapists are another interdisciplinary team member who may play a valuable 
role in breast cancer survivorship care, as exercise is vital in both the prevention of recurrent 
cancers and improvement of cancer and treatment related fatigue (Alberta Health Services, 2015; 
Luctkar-Flude et al., 2015a). In addition to these providers, dieticians could also be utilized for 
those breast cancer survivors interested in improving their health and preventing cancer 
recurrence through nutrition (Vander Meer, Vallance, Ball, Johnson, 2017). Financial hardships 
are also often a consequence of breast cancer and its treatment and as such, social workers may 
have a valuable role in breast cancer survivorship care.  
A team-based approach to care facilitates the delivery of holistic, patient-centered, 
evidence-based breast cancer survivorship care, which is the foundation of optimal patient 
outcomes. However, access to interdisciplinary teams may not be as straightforward in rural and 
remote communities (Olson et al., 2014). In these cases, services provided by telehealth may 
have a role in better meeting the needs of breast cancer survivors. However, this topic exceeds 
the scope of this paper and further exploration and research is needed on how best to meet the 
needs of rural- and remote-living breast cancer survivors. Either way, fragmented survivorship 
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care secondary to PCP knowledge deficits and workload demands is unjustified in a system that 
recognizes the value of a team-based approach to care.  
Oncologist Support.  Suboptimal support from oncologists was highlighted in a number 
of studies as a significant barrier for PCPs to take over breast cancer survivorship care, and 
provide evidence-based care to breast cancer survivors (Kantsiper et al., 2009; Luctkar-Flude et 
al., 2018; O’Brien et al., 2015). The most common complaints raised by some PCPs in these 
studies were that verbal communication with oncologists tended to be lacking in timeliness and 
written communication tended to be incomplete. A lack of timely and effective communication 
between oncologists and PCPs can create numerous issues that compromise the care of breast 
cancer survivors within a primary health care context.  
The transition of breast cancer survivors from oncologists to PCPs after active cancer 
treatment ends can pose a barrier to continuity of care if communication is limited. Without 
written communication from oncologists in the form of a discharge letter, PCPs are likely 
unaware of their newfound responsibility to follow a breast cancer survivor, which can lead to 
PCP role ambiguity (Dawes et al., 2015; Kantsiper et al., 2009; Virgo et al., 2013). Moreover, 
suboptimal communication during the transition of breast cancer survivors back to their PCPs 
can lead to significant components of breast cancer survivorship care being missed and thus, 
fragmented care and poor patient outcomes. 
The research evidence suggests that this transition can be improved with better 
communication with oncologists. In regards to written communication, a key piece of 
information required to adequately care for a breast cancer survivor is a discharge letter from the 
oncologist that highlights crucial information regarding the imminent transfer of care, as well as 
the patient’s diagnosis, cancer treatment, and summary of active issues requiring ongoing follow-
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up or intervention (Smith et al., 2011). These are components of care that cannot be found in 
evidence-based guidelines as they are unique to an individual breast cancer survivor. If done 
well, a discharge letter from oncologists could significantly decrease PCPs’ ambiguity around 
what type of follow-up care is needed for each diverse patient and what their expected role is in 
that care. It is important to note that one of the studies in this review provided evidence that a 
high number of PCPs always receive a discharge letter from oncologists (Smith et al., 2011). At 
the same time, this study also found that PCPs felt having more complete information provided 
by oncologists would better facilitate breast cancer survivorship care. Therefore, beyond 
receiving a discharge letter from oncologists, it is important that the letter contains the most 
pertinent information related to the breast cancer survivor. 
Along with improved written communication where it is needed, strategies aimed at 
enhancing timely verbal communication between oncologists and PCPs is vital to improving 
breast cancer survivorship care. It is important to note that only three of the five studies on 
system-related barriers to breast cancer survivorship care reported an issue with verbal 
communication with oncologists (Kantsiper et al., 2009; Luctkar-Flude et al., 2018; O’Brien et 
al., 2015). Therefore, an improvement in communication between providers does not apply to 
every setting. For those settings where it does apply, a key strategy to improve timely 
communication could be to utilize NPs in the cancer survivorship role. Since the expectation 
would be that these NPs are experts in cancer care, part of their role could involve providing 
consultative support to PCPs without this advanced knowledge. This could decrease the need for 
PCPs to require prompt access to oncologists. The use of NPs with specialized education in 
cancer care could also potentially improve communication between tertiary and primary health 
care settings, as these PCPs likely have already developed strong working relationships with 
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communities’ oncologists. Nonetheless, timely access to consultation with a health care provider 
with advanced knowledge in cancer care facilitates buy-in of a PCP-led care model and 
evidence-based care of breast cancer survivors.  
Summary of Recommendations 
The review of the relevant literature demonstrated various barriers PCPs encounter in 
providing breast cancer survivorship care in the primary health care setting. In order to improve 
the care of breast cancer survivors, strategies must be aimed at overcoming those barriers that 
currently exist.  
Addressing provider-related barriers, including PCP knowledge deficits and attitudes, is 
warranted. The first recommendation to overcome these barriers includes incorporating breast 
cancer survivorship education in the curricula of undergraduate and graduate programs to ensure 
PCPs have the foundational knowledge to care for breast cancer survivors in entry-level practice. 
In addition to this, ensuring PCPs have access to continuing education opportunities on 
components of breast cancer survivorship care is essential to help PCPs remain up-to-date on this 
type of care as it continues to evolve. In regards to evidence-based guidelines, knowledge 
translation strategies should be employed when new guidelines are created in order to improve 
access and uptake of these research findings by PCPs in practice. Furthermore, the use of NPs 
trained in both cancer treatment and survivorship could have a pivotal role in improving breast 
cancer survivorship care in the primary health care setting. Therefore, similar to breast cancer 
patients receiving active cancer treatment, breast cancer survivors could be seen by a subset of 
PCPs with additional education, awareness, experience, and interest in caring for this population 
of women.  
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Identifying system-related barriers including PCP workload and oncologist support are 
also necessary. A key recommendation to overcome these barriers includes a team-based 
approach to care, which is a reasonable alternative to PCPs working in silos. A team-based 
approach to care supports and encourages the use of interdisciplinary team members in the 
primary health care context to assist PCPs in meeting the multidimensional needs of breast 
cancer survivors. In regards to fostering optimal oncologist support for PCPs, there are ways to 
improve communication between oncologists and PCPs. The completion of discharge letters 
written by oncologists supports a smooth transition of breast cancer survivors back to the 
primary health care setting, as it provides the essential details of a patient’s diagnosis, cancer 
treatment, and concerns needing to be followed up on by the PCP. This discharge letter also 
decreases role ambiguity of PCPs, as it highlights that the oncologist is no longer following the 
breast cancer survivor. Furthermore, timely access to experts in cancer care is imperative to those 
PCPs caring for breast cancer survivors. NPs with advanced education in cancer care could be 
utilized to provide consultative support to generalized PCPs and improve communication 
between tertiary cancer centres and primary health care settings.   
Based on analysis of the literature reviewed for this paper, each of the above-mentioned 
recommendations has the potential to significantly improve the care of breast cancer survivors if 
implemented. Perhaps, above all else, these recommendations facilitate buy-in of a PCP-led 
model of breast cancer survivorship care. Breast cancer survivorship care that is delivered by 
PCPs with a desire to have a role in caring for breast cancer survivors, rather than PCPs who feel 







Surviving breast cancer is no longer an unattainable prospect. Due to earlier recognition 
and advances in cancer treatment, increasing numbers of women are surviving breast cancer. 
Although surviving cancer is a positive event in one’s life, it is also linked to numerous acute, 
chronic, late, and/or permanent effects spanning physical, emotional, mental, and social domains 
of health. Therefore, the complexity of care a breast cancer survivor requires should not be 
underestimated. In Canada, these women are transitioned back to their PCPs, including NPs and 
physicians, soon after their cancer treatment is complete. Therefore, PCPs are responsible for 
providing breast cancer survivorship care to these cancer survivors.  
The growing number of breast cancer survivors in Canada, along with preliminary 
research on issues hindering PCPs from delivering evidence-based care to this population, led me 
to the research question: what are the barriers that PCPs encounter in providing breast cancer 
survivorship care in the primary health care setting to women who have completed active cancer 
treatment in Canada? A comprehensive and systematic literature review was undertaken and 
resulted in 11 studies pertaining to this research question.  
The review of the relevant literature demonstrated two types of overarching barriers PCPs 
experience including provider-related barriers, and system-related barriers. Provider-related 
barriers consisted of knowledge deficits related to education, awareness, and experience; and 
attitudes related to preferences in breast cancer survivorship care models and role ambiguity. 
System-related barriers involved workload demands and perceived suboptimal oncologist 
support. Together, these identified provider and system-related barriers can guide key strategies 
to improve PCPs’ ability to provide evidence-based breast cancer survivorship care.  
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 This study enhances understanding of the multifaceted barriers affecting the ability of 
PCPs to provide optimal breast cancer survivorship care in the primary health care setting. More 
importantly, this study guided key strategies to overcome these barriers which are the basis of the 
following recommendations for improvement including: adding breast cancer survivorship 
education in undergraduate and postgraduate education programs for PCPs; providing PCPs with 
continuing education opportunities on breast cancer survivorship care; utilizing knowledge 
translation strategies to disseminate evidence-based guidelines on breast cancer survivorship 
care; utilizing a team-based approach to breast cancer survivorship care; improving the transition 
of breast cancer survivors back to their PCPs by reinforcing the completion of discharge letters 
by oncologists; and expanding PCPs’ access to experts in cancer care. Perhaps the most 
important strategy to overcome the barriers outlined includes creating a system that utilizes a 
subset of PCPs with a specialty in cancer care, such as NPs trained in both cancer treatment and 
survivorship, to provide care to breast cancer survivors and support interdisciplinary teams. 
Together, these strategies have the potential to close the gap in breast cancer survivorship care in 
Canada.  
Each of the above-mentioned recommendations are promising options deserving further 
attention. As such, future research efforts should be directed at building on identified strengths 
and opportunities to improve PCPs’ ability to deliver evidence-based breast cancer survivorship 
care. Improving the care of breast cancer survivors remains crucial in order to improve the 
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Additional cancer treatment in the form of radiation given after the 
primary or initial cancer treatment, which may include surgery, 
chemotherapy, biological therapy, targeted therapy, or hormone 
therapy.  
All-cause mortality Total number of deaths due to a certain circumstance, condition, or 
disease, within a specified period of time.  
Aromatase inhibitor A type of hormone therapy used to treat breast cancer in estrogen-
receptor positive post-menopausal women. 
Axillary lymph node 
dissection 
Surgical procedure to remove lymph nodes from the armpit (axilla), 
which can be implicated in breast cancer. 
Benign cells A medical term for normal cells. 
Biomarkers A biological molecule found in bodily fluids or tissue that signifies a 
normal or abnormal process, condition, or disease.  
Brachytherapy A form of radiation therapy in which radioactive material is placed 
directly into or near a tumor.  
BRCA1 and BRCA2 Human genes that act as a tumor suppressor by helping to repair 
damaged DNA. When one or both of these genes are mutated cells 
may not be repaired properly, which can lead to the development of 
cancer. Mutations to these genes can be inherited and most notably 
increase the risk of breast and ovarian cancers, but are also associated 
with several different types of cancers.  
Cancer A medical term for diseases in which abnormal or malignant cells 
divide uncontrollably and have the ability to invade nearby tissues. 
Carcinoma insitu  An early form of cancer that has not spread to nearby tissue 
Connective tissue Group of tissues that supports or binds other tissues or organs in the 
body. 
Core needle biopsy A procedure that extracts a tissue sample with a wide needle for 
microscopic examination.  
Duct A thin tube in the breast that allows the transfer of milk from the 
breast lobules to the nipple. 
Epithelial cells Cells that line the inner and outer surfaces of the body and act as a 
protective barrier.  
Estrogen receptor 
(ER) 
A protein found inside the cells of different types of tissue (i.e. 
female reproductive tissue) and some types of cancer cells. These 
receptors are activated by the hormone estrogen and may cause 
cellular growth.   
External beam 
radiation therapy 




A procedure that extracts cells or tissues with a thin needle for 
microscopic examination.  
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First degree relative An individual’s parent, sibling, or child. 
Human epidermal 
growth factor receptor 
2 (HER-2) 
A protein found inside the cells of different types of tissue and some 
types of cancer cells. These receptors are involved in cellular growth 
and may be expressed in large amounts in certain types of cancer 
including breast, ovarian, bladder, pancreatic, and stomach cancers, 
which can enable cancer cells to grow more rapidly.  
Breast lobule A gland on the inside of the breast that produces milk.   
Lumpectomy A breast-conserving surgical procedure that removes the breast 
cancer lump, as well as some of the tissue around the site, but not the 
breast itself.  
Lymphedema A condition characterized by tissue swelling caused by lymph fluid 
being unable to drain due to lymph vessels being blocked, damaged, 
or removed by surgery. 
Malignant cells A medical term for cancerous cells. 
Mammography The use of an x-ray to create a picture of the breast tissue and scan for 
cancer. 
Mortality A medical term referring to death and often expressed as a death rate, 
which would reflect the number of deaths due to a certain 
circumstance, condition, or disease, within a specified period of time. 
Neoadjuvant Therapy 
(NAT) 
Cancer treatment in the form of chemotherapy, radiation therapy, 
and/or hormone therapy given before the main cancer treatment 
(usually surgery) in order to shrink the tumor and render it operable. 
Oncogene A medical term used to describe a mutated gene of a gene involved in 
normal cellular growth. Oncogenes may lead to abnormal cancer cell 
growth.  
Oncogenomic tests Tests used to better understand the biology of a specific tumor by 
identifying certain cancer-related genes. These tests can lead to a 
better understanding of prognosis and viable treatment options.   
Partial mastectomy A breast-conserving surgical procedure that removes the area of the 
breast where cancer is present (often larger than a lump), as well as 
some of the tissue around the site, and the lining over the chest 
muscle if required.   
Pectoralis major 
muscle 
A fan-shaped muscle in the upper chest, spanning across the chest 
from the shoulder to the breastbone. 
Peripheral neuropathy A condition that causes pain, sensation loss, and weakness secondary 
to nerve damage in different parts of the body. It may be caused by 
cancer and/or its treatment, as well as different mechanisms of nerve 
injury. 
Primary care First line medical services and care. 
Primary health care A holistic approach to health care delivery that encompasses the 
majority of an individual’s health needs throughout their lifetime 
through a spectrum of health services. 
Progesterone receptor 
(PR) 
A protein found inside the cells of different types of tissue (i.e. 
female reproductive tissue) and some types of cancer cells. These 




Proto-oncogene A medical term used to describe a normal gene involved in cellular 
growth. Mutations to this gene may change it into an oncogene, 
which may lead to abnormal cancer cell growth.  
Punch biopsy A procedure that extracts a small round piece of tissue with a sharp 
circular instrument for microscopic examination. 
Radioactive material Material that has the ability to give off radiation. 
Regional lymph node A lymph node that drains lymph fluid from the area around a tumor. 
Data saturation Defined in research as the point when no new themes or information 
are discovered in the data. 
Scope of practice Refers to activities that a healthcare practitioner is authorized to 
perform within their professional license to practice.  
Segmental 
mastectomy 
A breast-conserving surgical procedure that removes the area of the 
breast where cancer is present (often larger than a lump), as well as 
some of the tissue around the site, and the lining over the chest 
muscle if required.   
Sentinel lymph node 
biopsy 
A procedure that involves the removal of the sentinel lymph node(s), 
which are the first lymph node(s) that would be involved in the 
spread of cancer cells from a primary tumor. If no cancer cells are 
detected in these lymph node(s) upon microscopic examination, there 
would be no reason for removal of other lymph nodes as cancer 
would not be suspected.  
Stereotactic core 
biopsy 
A procedure that involves the use of an ultrasound, CT scan, or MRI, 
in order to find the exact location of a tumour for removal and 
microscopic examination.  
Stromal cell A type of cell that constructs certain types of connective tissue that 
surrounds tissues and organs. 
Surgical biopsy A surgical procedure that involves the removal of tissue for 
microscopic examination.  
Systemic radiation 
therapy 
A type of radiation therapy in which a radioactive substance is given 
by mouth or injected into a vein so that it can travel throughout the 
bloodstream in the body to locate and kill circulating tumor cells.  
Tamoxifen A drug used to treat and/or prevent estrogen receptor-positive breast 
cancer, meaning the cancer can grow from the hormone estrogen. It 
works by blocking the effects of estrogen in the breast tissue, which 
keeps the cancer cells from growing.  
Tertiary health care Highly specialized medical care by specialists (i.e. oncologists) 
working in a facility that has trained providers for advanced and 
complex procedures (i.e. chemotherapy, radiation, etc.).  
Trastuzumab A drug used to treat HER2-positive breast cancer. It works by 
binding to a protein called HER2, which may help the immune 
system kills the cancer cells.  
Triple negative breast 
cancer 
A diagnosis used to define breast cancer that tests negative for all of 
the following receptors that cause cancer growth including estrogen, 
progesterone, and HER-2. Triple negative breast cancer is usually 
more aggressive and difficult to treat because hormone blocking 
treatment is ineffective.  
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Tumor Tumors may be benign (non-cancerous) or malignant (cancer) and are 
abnormal masses of tissue that result from abnormal cellular growth. 
Wide local excision A breast-conserving surgical procedure that involves the excision of 
cancer, as well as some of the tissue around the site.   
Wire localization 
biopsy 
An image guided procedure that involves the placement of a thin wire 
to mark the location of a lump of abnormal tissue, where an 

































































































































































































































































































































































Limiters: July 2008 – July 2018 (all); English (CINAHL, Medline); Peer-reviewed (CINAHL, 
Medline) 
 
CINAHL with Full Text: Total identified articles: 928 
Medline with Full Text: Total identified articles: 1706 
PubMed with Full Text: Total identified articles: 943 
 




Stage One and Two Search Results August 1, 2018 – Web Search 
Terms Google Scholar 
All Words: 
“Breast Cancer Survivorship” AND “Primary Care Providers” 
 
Exact Phrase: 
“Breast Cancer Survivorship” 
 
With at least one word: 




Limiters: 2008 – 2018 
 























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
9
6
  
- 
se
lf
-r
ep
o
rt
ed
 d
at
a 
m
ay
 
h
av
e
 i
n
tr
o
d
u
ce
d
 s
o
ci
al
 
d
es
ir
ab
il
it
y
 b
ia
s 
 
P
re
d
ic
to
rs
 o
f 
K
n
o
w
le
d
g
e:
 
- 
th
e 
le
ss
 c
o
n
fi
d
en
t 
p
h
y
si
ci
an
s 
w
er
e 
in
 p
ro
v
id
in
g
 B
C
S
 
ca
re
, 
th
e
 l
es
s 
k
n
o
w
le
d
g
e 
th
ey
 h
a
d
 a
ro
u
n
d
 t
h
e 
la
te
 a
n
d
 
lo
n
g
-t
er
m
 e
ff
ec
ts
 i
f 
ch
em
o
th
er
ap
y
. 
 
- 
th
e 
m
o
re
 b
re
as
t 
ca
n
ce
r 
su
rv
iv
o
rs
 s
ee
n
 p
er
 y
ea
r,
 t
h
e 
m
o
re
 k
n
o
w
le
d
g
e 
p
h
y
si
ci
an
s 
h
ad
 o
n
 t
h
e 
p
h
y
si
ca
l 
ef
fe
ct
s 
o
f 
tr
ea
tm
en
t.
  
 
D
aw
es
 e
t 
al
. 
(2
0
1
5
) 
 U
n
it
ed
 S
ta
te
s 
 E
x
p
la
n
at
o
ry
 
se
q
u
en
ti
al
 
m
ix
ed
 
m
et
h
o
d
s 
st
u
d
y
 
u
si
n
g
 
q
u
an
ti
ta
ti
v
e 
su
rv
ey
s 
an
d
 
q
u
al
it
at
iv
e 
fo
cu
s 
g
ro
u
p
s 
– 
S
tr
at
a/
IC
 
st
at
is
ti
ca
l 
so
ft
w
ar
e 
an
d
 
th
em
at
ic
 
an
a
ly
si
s 
P
C
P
s 
k
n
o
w
le
d
g
e,
 
at
ti
tu
d
es
, 
an
d
 
co
n
fi
d
en
ce
 i
n
 
d
el
iv
er
in
g
 B
C
S
 
ca
re
. 
N
 =
 4
2
 
P
ri
m
ar
y
 c
ar
e 
p
h
y
si
ci
an
s 
N
 =
 1
3
 
N
P
s 
N
 =
 4
 
P
h
y
si
ci
an
 
as
si
st
an
ts
 
S
tr
en
g
th
s:
 
- 
5
1
%
 r
es
p
o
n
se
 r
at
e
 
(q
u
an
ti
ta
ti
v
e 
su
rv
ey
s)
 
- 
u
se
 o
f 
th
e 
S
P
A
R
C
C
S
 
in
st
ru
m
en
t 
 
- 
ad
e
q
u
at
e 
n
u
m
b
er
 o
f 
p
ar
ti
ci
p
an
ts
 a
t 
fo
cu
s 
g
ro
u
p
s 
- 
fo
cu
s 
g
ro
u
p
s 
ta
p
ed
 
re
co
rd
ed
 a
n
d
 t
ra
n
sc
ri
b
ed
 
v
er
b
at
im
 
 W
e
ak
n
es
se
s:
 
- 
sm
al
l 
sa
m
p
le
 s
iz
e
/s
m
al
l 
g
eo
g
ra
p
h
ic
al
 r
eg
io
n
 s
tu
d
ie
d
 
(f
o
r 
q
u
an
ti
ta
ti
v
e 
d
at
a)
 
- 
fo
cu
s 
g
ro
u
p
s 
m
ay
 h
av
e 
el
ic
it
ed
 f
al
se
 d
at
a 
in
 
co
m
p
ar
is
o
n
 t
o
 i
n
d
iv
id
u
al
 
se
ss
io
n
s 
d
u
e 
to
 f
ea
r 
o
f 
ju
d
g
em
en
t 
- 
d
at
a 
sa
tu
ra
ti
o
n
 n
o
t 
co
n
fi
rm
ed
 
 
P
C
P
s’
 P
re
fe
rr
ed
 S
u
rv
iv
o
rs
h
ip
 C
a
re
 M
o
d
el
: 
- 
4
0
%
 –
 o
n
co
lo
g
is
t-
le
d
 c
ar
e 
m
o
d
el
 
- 
2
8
%
 -
 s
p
ec
ia
li
ze
d
 c
li
n
ic
 m
o
d
el
 
- 
2
2
%
 -
 s
h
ar
ed
-c
a
re
 m
o
d
el
 
- 
1
0
%
 -
 P
C
P
-l
ed
 c
ar
e 
m
o
d
el
 
 P
C
P
s’
 K
n
o
w
le
d
g
e 
in
 C
o
m
p
o
n
en
ts
 o
f 
B
C
S
 C
a
re
: 
“
St
ro
ng
ly
”
 o
r 
“
So
m
ew
ha
t”
 a
gr
ee
d
 
- 
6
3
%
 f
el
t 
th
ey
 h
ad
 t
h
e 
k
n
o
w
le
d
g
e 
to
 m
o
n
it
o
r 
fo
r 
ca
n
ce
r 
re
cu
rr
en
ce
 
• 
o
n
ly
 1
0
%
 o
f 
re
sp
o
n
d
en
ts
 o
rd
er
ed
 s
u
rv
ei
ll
a
n
ce
 
te
st
in
g
 t
h
at
 c
o
m
p
li
ed
 w
it
h
 b
re
as
t 
ca
n
ce
r 
su
rv
iv
o
rs
h
ip
 g
u
id
el
in
es
 
- 
3
9
%
 f
el
t 
th
ey
 h
ad
 t
h
e 
k
n
o
w
le
d
g
e 
to
 p
ro
v
id
e 
o
th
er
 
as
p
ec
ts
 o
f 
B
C
S
 c
ar
e.
 
- 
2
9
%
 f
el
t 
th
ey
 w
er
e 
b
et
te
r 
su
it
ed
 t
o
 o
ff
er
 p
sy
ch
o
so
ci
al
 
su
p
p
o
rt
 t
h
an
 o
n
co
lo
g
is
ts
 
 P
C
P
s’
 C
o
n
fi
d
en
ce
 i
n
 P
ro
v
id
in
g
 B
C
S
 C
a
re
: 
“
V
er
y 
co
nf
id
en
t”
 
- 
2
5
%
 -
 m
an
ag
in
g
 p
sy
ch
o
so
ci
al
 e
ff
ec
ts
  
- 
2
2
%
 -
 p
ro
v
id
in
g
 a
p
p
ro
p
ri
at
e 
su
rv
ei
ll
an
ce
 
- 
1
4
%
 -
 m
an
ag
in
g
 p
h
y
si
ca
l 
ef
fe
ct
s 
 P
ro
v
id
er
-r
e
la
te
d
 B
a
rr
ie
rs
: 
- 
ro
le
 a
m
b
ig
u
it
y
 
- 
k
n
o
w
le
d
g
e
 d
ef
ic
it
s 
re
la
te
d
 t
o
 o
n
g
o
in
g
 h
o
rm
o
n
al
 
th
er
ap
y
 r
eg
im
en
s 
9
7
  
S
y
st
em
-r
e
la
te
d
 B
a
rr
ie
rs
: 
- 
co
n
c
er
n
s 
o
v
er
 t
im
in
g
 o
f 
tr
an
si
ti
o
n
 
 F
a
ci
li
ta
to
rs
: 
- 
ad
d
it
io
n
al
 t
ra
in
in
g
 i
n
 c
an
ce
r 
sp
ec
if
ic
 c
ar
e 
 
- 
u
se
 o
f 
su
rv
iv
o
rs
h
ip
 c
ar
e 
p
la
n
s 
 
 
S
m
it
h
 e
t 
al
. 
(2
0
1
5
) 
 C
an
ad
a 
 Q
u
an
ti
ta
ti
v
e 
cr
o
ss
-s
ec
ti
o
n
al
 
st
u
d
y
 u
si
n
g
 
su
rv
ey
s 
– 
st
an
d
ar
d
 
u
n
iv
ar
ia
te
 
st
at
is
ti
cs
  
P
er
ce
p
ti
o
n
s 
o
f 
b
re
as
t 
ca
n
ce
r 
su
rv
iv
o
rs
 a
n
d
 
p
ri
m
ar
y
 c
ar
e 
p
h
y
si
ci
an
s 
in
 
re
g
ar
d
s 
to
 t
h
e 
ab
il
it
y
 o
f 
p
h
y
si
ci
an
s 
to
 
p
ro
v
id
e 
B
C
S
 c
ar
e.
  
N
 =
 1
0
6
5
  
B
re
a
st
 c
an
ce
r 
su
rv
iv
o
rs
 
N
 =
 5
8
7
 
P
ri
m
ar
y
 c
ar
e 
p
h
y
si
ci
an
s 
S
tr
en
g
th
s:
 
- 
su
rv
ey
s 
p
il
o
t-
te
st
ed
 
- 
5
9
%
 r
es
p
o
n
se
 r
at
e 
fo
r 
p
h
y
si
ci
an
s;
 4
7
%
 r
es
p
o
n
se
 
ra
te
 f
o
r 
b
re
as
t 
ca
n
c
er
 
su
rv
iv
o
rs
 
- 
la
rg
e 
sa
m
p
le
 s
iz
e
 
 W
e
ak
n
es
se
s:
 
- 
su
rv
ey
 i
n
st
ru
m
en
ts
 n
o
t 
ri
g
o
ro
u
sl
y
 v
al
id
at
ed
 
- 
p
o
ss
ib
il
it
y
 o
f 
re
sp
o
n
se
-
b
ia
s 
- 
u
n
cl
ea
r 
if
 t
h
e 
b
re
as
t 
ca
n
ce
r 
su
rv
iv
o
r 
p
ar
ti
ci
p
an
ts
 w
er
e 
re
q
u
ir
ed
 t
o
 b
e 
d
is
ch
a
rg
ed
 
fr
o
m
 t
h
ei
r 
o
n
co
lo
g
is
t 
in
 
o
rd
er
 t
o
 b
e 
el
ig
ib
le
 t
o
 
p
ar
ti
ci
p
at
e 
in
 t
h
is
 s
tu
d
y
 
P
C
P
s’
 C
o
n
fi
d
en
ce
 i
n
 P
ro
v
id
in
g
 B
C
S
 C
a
re
: 
- 
80
%
 o
f 
pr
im
ar
y 
ca
re
 p
hy
si
ci
an
s 
de
sc
ri
be
d 
“g
oo
d”
 o
r 
“a
de
q
ua
te
” 
co
nf
id
en
ce
 i
n 
th
ei
r 
ab
il
it
y 
to
 m
an
ag
e 
al
l 
co
m
p
o
n
en
ts
 o
f 
B
C
S
 c
ar
e.
  
- 
m
o
st
 c
o
n
fi
d
en
t 
in
 s
u
rv
ei
ll
an
ce
 p
ra
ct
ic
es
 s
u
ch
 a
s 
sc
re
en
in
g
 f
o
r 
re
cu
rr
en
ce
, 
w
it
h
 a
p
p
ro
x
im
at
el
y
 7
5
%
 o
f 
re
sp
o
n
d
en
ts
 r
ep
o
rt
in
g
 a
 “
go
o
d”
 a
bi
li
ty
 i
n 
th
is
 c
ar
e 
co
m
p
o
n
en
t.
  
- 
le
as
t 
co
n
fi
d
en
t 
in
 d
el
iv
er
in
g
 f
am
il
y
 c
o
u
n
se
ll
in
g
 
(2
4
%
),
 p
ro
v
id
in
g
 s
ex
 a
n
d
 b
o
d
y
 i
m
ag
e 
co
u
n
se
ll
in
g
 
(2
6
%
),
 a
n
d
 m
an
ag
in
g
 l
y
m
p
h
ed
em
a 
(2
4
%
).
  
 B
re
a
st
 C
a
n
ce
r 
S
u
rv
iv
o
r
s’
 C
o
n
fi
d
en
ce
 i
n
 P
C
P
s 
A
b
il
it
y
 t
o
 P
ro
v
id
e 
B
C
S
 C
a
re
: 
- 
b
re
a
st
 c
an
ce
r 
su
rv
iv
o
rs
 w
er
e 
co
n
fi
d
en
t 
in
 p
ri
m
ar
y
 
ca
re
 p
hy
si
ci
an
s’
 a
bi
li
ty
 t
o 
pr
ov
id
e 
B
C
S
 c
ar
e 
as
 w
el
l,
 
h
o
w
ev
er
 l
es
s 
so
 t
h
an
 p
h
y
si
ci
an
s 
w
er
e.
  
- 
m
os
t 
co
nf
id
en
t 
in
 P
C
P
s’
 a
bi
li
ty
 t
o 
sc
re
en
 f
or
 
re
cu
rr
en
ce
 (
6
5
%
) 
- 
le
as
t 
co
nf
id
en
t 
in
 P
C
P
s’
 a
b
il
it
y
 t
o
 d
el
iv
er
 f
am
il
y
 
co
u
n
se
ll
in
g
 (
4
1
%
) 
o
r 
se
x
 a
n
d
 b
o
d
y
 i
m
ag
e 
co
u
n
se
ll
in
g
 
(3
6
%
).
 
 
O
’B
ri
en
 e
t 
al
. 
(2
0
1
5
) 
 C
an
ad
a 
 
E
x
p
er
ie
n
ce
s 
o
f 
fa
m
il
y
 p
h
y
si
ci
an
s 
in
 t
h
ei
r 
ro
le
 o
f 
p
ro
v
id
in
g
 B
C
S
 
ca
re
 a
n
d
 
aw
ar
e
n
es
s 
ab
o
u
t 
N
 =
 1
8
 
P
ri
m
ar
y
 c
ar
e 
p
h
y
si
ci
an
s 
S
tr
en
g
th
s:
 
- 
d
iv
er
se
 c
h
ar
ac
te
ri
st
ic
s 
w
it
h
in
 p
ar
ti
ci
p
an
t 
sa
m
p
le
 
- 
in
te
rv
ie
w
s 
co
n
d
u
ct
ed
 b
y
 
o
n
e 
re
se
ar
ch
er
 
P
C
P
s’
 P
re
fe
rr
ed
 S
u
rv
iv
o
rs
h
ip
 C
a
re
 M
o
d
el
: 
- 
m
o
st
 p
h
y
si
ci
an
s 
fe
lt
 w
el
l-
su
it
ed
 t
o
 p
ro
v
id
e 
B
C
S
 c
ar
e 
b
u
t 
w
er
e 
n
o
t 
co
m
fo
rt
ab
le
 t
ak
in
g
 o
n
 t
h
is
 r
o
le
 u
n
ti
l 
th
re
e 
to
 f
iv
e-
y
ea
rs
 p
o
st
 d
ia
g
n
o
si
s.
  
 P
C
P
s’
 K
n
o
w
le
d
g
e 
in
 C
o
m
p
o
n
en
ts
 o
f 
B
C
S
 C
a
re
: 
9
8
  
D
es
cr
ip
ti
v
e 
q
u
al
it
at
iv
e 
st
u
d
y
 u
si
n
g
 
se
m
i-
st
ru
ct
u
re
d
 
in
te
rv
ie
w
s 
–
 
co
n
st
an
t 
co
m
p
ar
at
iv
e 
an
a
ly
si
s 
 
th
ei
r 
p
er
ce
p
ti
o
n
s 
o
f 
S
u
rv
iv
o
rs
h
ip
 
C
ar
e 
P
la
n
s 
(S
C
P
) 
an
d
 o
n
co
lo
g
is
t 
d
is
ch
ar
g
e 
le
tt
er
s.
 
 
- 
in
te
rv
ie
w
s 
o
n
e
-o
n
-o
n
e,
 
w
h
ic
h
 m
in
im
iz
ed
 t
h
e 
p
o
ss
ib
il
it
y
 o
f 
so
ci
al
 
d
es
ir
ab
il
it
y
 b
ia
s.
  
 
- 
in
te
rv
ie
w
s 
au
d
io
ta
p
ed
 a
n
d
 
tr
an
sc
ri
b
ed
 v
er
b
at
im
 
- 
d
at
a 
sa
tu
ra
ti
o
n
 c
o
n
fi
rm
ed
 
- 
au
th
o
rs
 u
ti
li
ze
d
 d
at
a 
m
an
ag
em
en
t 
p
ro
g
ra
m
 t
o
 
m
ai
n
ta
in
 a
n
 a
u
d
it
 t
ra
il
 
 W
e
ak
n
es
se
s:
 
- 
n
o
n
e 
n
o
te
d
 
 
- 
id
en
ti
fi
ed
 k
n
o
w
le
d
g
e 
g
ap
s 
in
 p
sy
ch
o
so
ci
al
 c
ar
e.
  
- 
p
h
y
si
ci
an
s 
p
er
ce
iv
ed
 B
C
S
 c
a
re
 a
s 
o
n
ly
 c
o
n
d
u
ct
in
g
 
cl
in
ic
al
 b
re
as
t 
ex
am
s 
an
d
 o
rd
er
in
g
 m
am
m
o
g
ra
m
s,
 
w
h
ic
h
 i
n
 a
ct
u
al
it
y
 i
s 
o
n
ly
 a
tt
en
d
in
g
 t
o
 t
h
e 
su
rv
ei
ll
an
ce
 
co
m
p
o
n
en
ts
 o
f 
ca
re
 r
eq
u
ir
ed
 
 S
y
st
em
-r
e
la
te
d
 B
a
rr
ie
rs
: 
- 
m
o
st
 v
o
ic
ed
 t
h
at
 a
 1
-p
ag
e 
re
co
rd
 o
f 
ca
re
 w
as
 t
h
e 
o
n
ly
 
u
se
fu
l 
as
p
ec
t 
o
f 
ca
n
ce
r 
su
rv
iv
o
rs
h
ip
 c
ar
e 
p
la
n
s.
 
- 
m
o
st
 p
h
y
si
ci
an
s 
fo
u
n
d
 r
em
in
d
er
 c
h
ec
k
li
st
s 
u
se
le
ss
, 
as
 
th
ey
 u
se
d 
on
li
ne
 s
ys
te
m
s 
w
it
h 
p
at
ie
nt
’s
 E
le
ct
ro
n
ic
al
 
M
ed
ic
al
 R
ec
o
rd
s 
(E
M
R
) 
to
 r
ec
al
l 
th
e 
p
at
ie
n
t.
 
- 
re
sp
o
n
d
en
ts
 h
ad
 v
ar
ia
b
le
 v
ie
w
s 
re
g
ar
d
in
g
 t
h
e 
v
al
u
e 
o
f 
o
n
co
lo
g
is
t 
d
is
ch
ar
g
e 
le
tt
er
s 
 
- 
m
o
st
 r
es
p
o
n
d
en
ts
 w
er
e 
co
n
ce
rn
ed
 r
eg
ar
d
in
g
 t
im
el
y
 
o
n
g
o
in
g
 c
o
m
m
u
n
ic
at
io
n
 w
it
h
 o
n
co
lo
g
is
ts
. 
 F
a
ci
li
ta
to
rs
: 
- 
su
m
m
ar
y
 o
f 
ca
n
ce
r 
tr
ea
tm
en
t 
o
n
 1
-p
ag
e
 r
ec
o
rd
 o
f 
ca
re
 
- 
em
p
o
w
er
in
g
 b
re
as
t 
ca
n
ce
r 
su
rv
iv
o
rs
 
- 
ti
m
el
y
 c
o
m
m
u
n
ic
at
io
n
 w
it
h
 o
n
co
lo
g
is
ts
 
 
L
u
ct
k
ar
-F
lu
d
e 
et
 a
l.
 
(2
0
1
5
b
) 
 C
an
ad
a 
 Q
u
an
ti
ta
ti
v
e 
cr
o
ss
-s
ec
ti
o
n
al
 
st
u
d
y
 u
si
n
g
 
su
rv
ey
s 
– 
st
an
d
ar
d
 
u
n
iv
ar
ia
te
 
st
at
is
ti
cs
  
A
sp
ec
ts
 o
f 
B
C
S
 
ca
re
 b
ei
n
g
 
im
p
le
m
en
te
d
 b
y
 
P
C
P
s,
 k
n
o
w
le
d
g
e 
g
ap
s 
an
d
 
d
if
fe
re
n
ce
s 
b
et
w
ee
n
 
p
h
y
si
ci
an
 a
n
d
 N
P
 
ca
re
 d
el
iv
er
y
. 
 
N
 =
 6
2
 
P
ri
m
ar
y
 c
ar
e 
p
h
y
si
ci
an
s 
 
N
 =
 2
0
 
N
P
s 
S
tr
en
g
th
s:
 
- 
st
ud
y’
s 
fi
nd
in
gs
 a
li
gn
 w
it
h 
p
re
v
io
u
s 
re
se
ar
ch
 f
in
d
in
g
s 
 W
e
ak
n
es
se
s:
 
- 
2
5
%
 r
es
p
o
n
se
 r
at
e 
- 
la
ck
 o
f 
d
iv
er
si
ty
 i
n
 
p
ar
ti
ci
p
an
t 
sa
m
p
le
  
- 
p
o
te
n
ti
al
 f
o
r 
re
sp
o
n
se
 b
ia
s 
P
C
P
s’
 K
n
o
w
le
d
g
e 
in
 C
o
m
p
o
n
en
ts
 o
f 
B
C
S
 C
a
re
: 
- 
le
ss
 t
h
an
 h
al
f 
(4
6
.4
%
) 
o
f 
th
e 
k
ey
 g
u
id
el
in
e 
re
co
m
m
en
d
at
io
n
s 
fo
r 
B
C
S
 c
a
re
 w
er
e 
b
ei
n
g
 
im
p
le
m
en
te
d
 b
y
 P
C
P
s.
  
- 
2
8
.5
%
 o
f 
th
o
se
 r
ec
o
m
m
en
d
at
io
n
s 
w
er
e 
u
n
k
n
o
w
n
 t
o
 
P
C
P
s.
  
- 
im
p
le
m
en
ta
ti
o
n
 r
at
es
 w
er
e 
h
ig
h
er
 f
o
r 
p
re
v
en
ti
o
n
 a
n
d
 
su
rv
ei
ll
an
ce
 a
sp
ec
ts
 o
f 
su
rv
iv
o
rs
h
ip
 c
ar
e,
 a
n
d
 l
o
w
er
 f
o
r 
m
an
ag
em
en
t 
o
f 
lo
n
g
-t
er
m
 p
h
y
si
ca
l 
an
d
 p
sy
ch
o
so
ci
al
 
ef
fe
ct
s 
o
f 
ca
n
ce
r 
an
d
 i
ts
 t
re
at
m
en
t.
  
 P
re
d
ic
to
rs
 o
f 
K
n
o
w
le
d
g
e:
 
- 
th
o
se
 c
ar
e 
co
m
p
o
n
en
ts
 w
it
h
 l
o
w
er
 i
m
p
le
m
en
ta
ti
o
n
 
ra
te
s 
w
er
e 
al
so
 a
re
as
 t
h
at
 k
n
o
w
le
d
g
e 
g
ap
s 
ex
is
te
d
. 
 
9
9
  
L
u
ct
k
ar
-F
lu
d
e 
et
 a
l.
 
(2
0
1
8
) 
 C
an
ad
a 
 Q
u
al
it
at
iv
e 
d
es
cr
ip
ti
v
e 
m
et
h
o
d
 –
 
se
m
i-
st
ru
ct
u
re
d
 
in
te
rv
ie
w
s 
 
B
ar
ri
er
s 
an
d
 
fa
ci
li
ta
to
rs
 r
el
at
ed
 
to
 P
C
P
s,
 
in
cl
u
d
in
g
 
p
h
y
si
ci
an
s 
an
d
 
N
P
s,
 
im
p
le
m
en
ti
n
g
 
ev
id
en
ce
-b
as
ed
 
B
C
S
 c
a
re
 
 
N
 =
 1
0
 
P
h
y
si
ci
an
s 
N
 =
 9
 
N
P
s 
 
S
tr
en
g
th
s:
 
- 
p
il
o
t-
te
st
ed
 o
n
e-
o
n
-o
n
e 
in
te
rv
ie
w
s 
- 
in
te
rv
ie
w
s 
co
n
d
u
ct
ed
 b
y
 
th
e 
sa
m
e 
re
se
ar
ch
er
 
- 
in
te
rv
ie
w
s 
re
co
rd
ed
 a
n
d
 
tr
an
sc
ri
b
ed
 v
er
b
at
im
 
- 
d
at
a 
sa
tu
ra
ti
o
n
 c
o
n
fi
rm
ed
  
- 
p
ee
r-
re
v
ie
w
, 
m
em
b
er
 
ch
e
ck
in
g
, 
an
d
 t
ri
an
g
u
la
ti
o
n
 
u
se
d
 i
n
 r
es
ea
rc
h
 p
ro
ce
ss
 
 W
e
ak
n
es
se
s:
 
- 
la
ck
 o
f 
d
iv
er
si
ty
 i
n
 
p
ar
ti
ci
p
an
t 
sa
m
p
le
 
  
F
o
u
n
d
 t
h
re
e 
m
aj
o
r 
th
em
es
 r
el
at
ed
 t
o
 b
ar
ri
er
s:
 1
) 
in
co
n
si
st
en
t 
ed
u
ca
ti
o
n
al
 p
re
p
ar
at
io
n
; 
2
) 
p
ro
v
id
er
 
an
x
ie
ti
es
; 
an
d
 3
) 
p
ri
m
ar
y
 c
ar
e 
b
u
rd
en
. 
 
 P
C
P
s’
 P
re
fe
rr
ed
 S
u
rv
iv
o
rs
h
ip
 C
a
re
 M
o
d
el
: 
- 
p
re
fe
re
n
ce
s 
in
 c
an
ce
r 
su
rv
iv
o
rs
h
ip
 c
ar
e 
m
o
d
el
s 
w
er
e 
d
iv
id
ed
, 
w
it
h
 s
o
m
e 
P
C
P
s 
fe
el
in
g
 i
t 
w
as
 n
o
t 
th
ei
r 
re
sp
o
n
si
b
il
it
y
, 
an
d
 o
th
er
s 
v
o
ic
in
g
 t
h
ey
 w
er
e 
id
ea
l 
ca
n
d
id
at
es
 t
o
 a
ss
u
m
e 
su
ch
 r
o
le
s.
  
 P
C
P
s’
 K
n
o
w
le
d
g
e 
in
 C
o
m
p
o
n
en
ts
 o
f 
B
C
S
 C
a
re
: 
- 
n
o
 f
o
rm
al
 e
d
u
ca
ti
o
n
 o
n
 B
C
S
 c
a
re
 a
n
d
 t
h
er
ef
o
re
, 
th
ey
 
ex
p
e
ri
en
ce
d
 c
h
al
le
n
g
es
 r
el
at
ed
 t
o
 k
n
o
w
le
d
g
e 
g
ap
s 
an
d
 
k
ee
p
in
g
 u
p
-t
o
-d
at
e 
w
it
h
 c
ar
e 
g
u
id
el
in
es
. 
 
 P
C
P
s’
 C
o
n
fi
d
en
ce
 i
n
 P
ro
v
id
in
g
 B
C
S
 C
a
re
: 
- 
fe
ar
s 
o
f 
m
ed
ic
al
-l
eg
al
 c
o
n
se
q
u
en
ce
s 
re
la
te
d
 t
o
 
p
at
ie
n
ts
 f
al
li
n
g
 t
h
ro
u
g
h
 t
h
e 
cr
ac
k
s 
an
d
 a
s 
su
ch
, 
h
av
in
g
 
ca
n
ce
r 
re
cu
rr
en
ce
 g
o
 u
n
n
o
ti
ce
d
. 
 
 P
re
d
ic
to
rs
 o
f 
C
o
n
fi
d
en
ce
: 
- 
in
d
iv
id
u
al
s 
w
it
h
 m
o
re
 c
o
n
fi
d
en
ce
 i
n
 p
ro
v
id
in
g
 c
ar
e 
to
 
su
rv
iv
o
rs
 w
er
e 
th
o
se
 w
it
h
 p
ri
o
r 
ex
p
er
ie
n
ce
. 
 S
y
st
em
-r
e
la
te
d
 B
a
rr
ie
rs
: 
- 
p
ri
m
ar
y
 c
ar
e 
w
o
rk
lo
ad
 w
o
u
ld
 n
o
t 
ac
co
m
m
o
d
at
e 
th
e 
h
ig
h
er
 a
c
u
it
y
 c
ar
e 
re
q
u
ir
ed
 f
o
r 
b
re
as
t 
ca
n
ce
r 
su
rv
iv
o
rs
. 
 
- 
in
cr
ea
se
d
 b
u
rd
en
 o
n
 a
d
m
in
is
tr
at
iv
e 
st
af
f 
re
la
te
d
 t
o
 
E
M
R
s 
an
d
 r
ec
al
l 
p
ro
ce
d
u
re
s.
  
- 
co
n
c
er
n
 o
v
er
 i
n
ad
eq
u
at
e 
ac
ce
ss
 t
o
 o
n
co
lo
g
is
ts
  
 F
a
ci
li
ta
to
rs
: 
- 
F
o
u
n
d
 t
h
re
e 
m
aj
o
r 
th
em
es
 r
el
at
ed
 t
o
 f
ac
il
it
at
o
rs
: 
1
) 
to
o
ls
 a
n
d
 t
ec
h
n
o
lo
g
y
; 
2
) 
em
p
o
w
er
in
g
 s
u
rv
iv
o
rs
; 
an
d
 3
) 
o
p
ti
m
iz
in
g
 n
u
rs
in
g
 r
o
le
s.
 
 
